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ABSTRACT
Jordan, Heidi Lynn.
PhD., Biomedical Sciences Ph.D. Program, Department of
Neuroscience, Cell Biology and Physiology, Wright State University, 2012.
The Role of AMP-Activated Protein Kinase (AMPK) in Hypoxic Chemotransduction by the
Carotid Body.

The carotid bodies are small sensory organs located along the bifurcation of the
carotid arteries. They detect changes in blood gases and relay this information to the brain
to allow for initiation of appropriate respiratory and cardiovascular responses. A decrease
in oxygen (hypoxia) sensed by the carotid body results in an increase in firing of the carotid
sinus nerve and ultimately a change in one’s breathing pattern. An inability to respond to
an acute hypoxic (low oxygen) episode via increased ventilation may result in death or lead
to pathological or chronic conditions such as stroke and hypertension (Prabhakar et.al.,
2005).

The carotid bodies are therefore responsible for initiating the acute hypoxic

ventilatory response (HVR) and blunting or attenuation of the HVR has been implicated in
sudden infant death syndrome (SIDS) in ‘at risk’ infant groups (Calder et al., 1994; Horne
et al., 2005; Gauda et. al., 2007).
The exact mechanism(s) responsible for hypoxic chemotransduction by the carotid
body remains controversial and are the subject of intense investigation. There is evidence
indicating the energy-sensing enzyme AMP-activated protein kinase (AMPK) may play a
critical role in the transduction of an acute hypoxic stimulus by the carotid bodies (Evans et.
al., 2005; Wyatt et.al., 2007). Global AMPK α1 and AMPK α2 subunit knockout mice were
used to gain further insight into the role AMPK has in acute oxygen-sensing in whole animal
and in isolated oxygen-sensing cells of mice carotid bodies.
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A two-chamber

plethysmography system was used to measure baseline breathing during normoxia (21% O2)
and the hypoxic ventilatory response to 8% oxygen. AMPK α1 subunit knockout mice had a
significant attenuation in percent change in breathing frequency during hypoxic exposure and
AMPK α2 knockouts also showed a significant decrease in percent change in minute
ventilation. The plethysmography data shows AMPKα subunits may be involved in baseline
breathing and generation of acute hypoxic ventilatory responses. Isolated type I cells from
global knockout mice were also used in calcium imaging experiments. Hypoxia induced
Ca2+ signaling was inhibited by 85% in cells from AMPK α2 knockout mice whereas AMPK
α1 KO mice showed a mixed response to hypoxia. The cellular data seem to show that a
decrease in response to hypoxia may be due to an effect at the level of the carotid body.
These findings provide further support for the hypothesis that AMPK regulates acute hypoxic
chemotransduction and thereby energy supply at the whole body level.
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Background
Carotid Body
Carotid bodies (CB) are small-paired sensory organs, which can be found along the
bifurcation of the carotid arteries (Figure 1). In 1926 Fernando De Castro discovered
that the cell bodies of the carotid sinus nerve (CSN) lay within the petrosal sensory
ganglion suggesting that the carotid body had sensory capabilities (De Castro, 1926). In
1928, De Castro went on to determine that the carotid body was indeed a sensory organ
and not a gland, which he hypothesized was capable of detecting changes in the
composition of blood (De Castro, 1928). From 1930-1933 Corneille Jean Francois
Heymans, a Belgium physiologist, focused most of his time working on De Castro’s
hypothesis of the CB being a chemoreceptor (De Castro, 2009). From these experiments,
Heymans and collaborators were able to demonstrate that hyperventilation induced by a
decrease in the partial pressure of oxygen in arterial blood (PaO2) and pH or an increase
in partial pressure of carbon dioxide in arterial blood (PaCO2) was mediated via the
carotid body (Heymans et.al.,1930). This work won Heymans the Nobel Prize in
Physiology or Medicine in 1938 (De Castro, 2009).
It is now known that the carotid bodies are the primary peripheral arterial
chemoreceptors (PAC) of mammals; they are responsible for sensing changes in the
partial pressure of oxygen (PO2), partial pressure of carbon dioxide (PCO2), and pH and
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Figure 1. Anatomical location of the carotid bodies.
The carotid bodies are small sensory organs located, bilaterally, at the bifurcation of the
common carotid arteries and branch into the internal and external carotid arteries. The
diagram indicates circulatory supply and the afferent nerve projections from the carotid
bodies to the nucleus tractus solitarius.
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Figure 1.
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act to produce an increase in ventilatory response (Heymans et. al., 1930). Upon CSN
resection, the hyperventilatory response ceased, thus illustrating the relationship between
the CB and the hypoxia-mediated stimulation of the respiration rate (Heymans et. al.,
1930).

Carotid bodies are perfused with blood via one or more small arteries that

originate near the branches of the carotid artery. Blood drains into the internal jugular
vein by one or two veins originating from a dense vascular plexus located on the surface
of the organ. Carotid bodies possess the highest blood flow relative to its size(1.5 and 2.0
liters100g-1 min-1) of any other organ in the body (Gonzalez et. al., 1994; Kumar & BinJaliah, 2007). Blood flow to the carotid body is important in determining the PO2 of the
carotid body tissue. The carotid body is highly vascularized, thus it is able to quickly
(within seconds) (Kumar, 2009) sense changes in arterial blood partial pressure of
oxygen (PO2), partial pressure of carbon dioxide (PCO2) and pH. The ability of the
carotid body to rapidly sense blood gas changes allows it to initiate appropriate
physiological responses to the changes in an expedient manner (Barnett et. al., 1988).
Carotid bodies sensory afferent innervations are from the carotid sinus nerve. Fibers from
the afferent innervation ultimately project to the nucleus tractus solitarius, (NTS) of the
medulla (Finley & Katz, 1992) and allow for initiation of respiratory and cardiovascular
reflexes to ensure proper oxygenation to vital organs (Lahiri et. al., 2006). Two main cell
types comprise the carotid body, glomus cells and sustentacular cells, which form clusters
surrounded by a dense net of fenestrated capillaries (Gonzalez et. al., 1992). Glomus
cells, also known as type I cells, are excitatory and originate from the neural crest,
whereas sustentacular cells (type II cells) are similar to glial cells. Current research
suggests type II cells in adult CB’s are functional and may be dormant stem cells which
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proliferate in response to hypoxia and differentiate into new glomus cells (Pardal et.al.,
2007). By contrast, glomus cells are more complex, expressing a number of voltage- and
ligand-gated ion channels in addition to transient receptor potential channels and
background K+ channels. Combinations of voltage-gated Na+, Ca2+, and K+ channels are
expressed and the level of expression varies among mammalian species. For example,
rabbit glomus cells have relatively large voltage gated inward Na+ currents, as well as
sustained Ca2+ currents (ICa) (Lopez-Barneo et. al., 1988; Ureña et. al., 1989; Duchen &
Biscoe, 1992), whereas, in rat type I cells, the Na+ current is either absent completely
(Peers & Green, 1991; Fieber & McCleskey, 1993) or is present only at low densities
(Stea & Nurse, 1991). Due to the presence of voltage-gated channels found within
glomus cells, most are excitable and able to elicit action potentials (Ureña et. al., 1989) or
calcium-dependent receptor potentials (Buckler & Vaughn-Jones, 1994).
Neurotransmitters (NT) found in the carotid body can be classified into two
different categories, conventional and unconventional. Conventional NT’s are located
within synaptic vesicles and their actions are mediated through activation of membranebound receptors often coupled to specific G-coupled proteins or ion channels.
Transmitters found in this category include: acetylecholine (ACh), dopamine (DA),
norepinephrine (NE), 5-hydroxytryptamine (5-HT), substance P (Sub. P), ATP and amino
acids (Lahiri et. al., 2006). Unconventional NT’s, which are not synaptically stored but
instead are generated spontaneously through enzymatic reactions and express their
biological actions via cytosolic enzymes or direct protein modifications. Examples of
unconventional NT’s would include nitric oxide (NO) and carbon monoxide (CO)
(Gonzalez et. al., 1994; Lahiri et. al., 2006; Prabhakar, 2006; Lopez-Barneo et .al., 2008).
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Release of neurotransmitters stimulates afferent nerve activity (i.e. ACh, Sub. P,
Adenosine, and ATP) (Prabhakar et. al., 1989; Zhang et. al., 2000; Spyer et.al., 2004)
whereas some such as dopamine will inhibit nerve activity (Carroll et. al., 2005; PrietoLloret et. al., 2007). Studies have shown that hypoxia induces release of both stimulatory
and inhibitory NT’s during afferent nerve activation (Ureña et. al., 1989; Xu et. al.,
2003); therefore, the balance of excitatory to inhibitory NT’s released determines
excitation.

CO2 and Acid Sensing
The carotid body is excited by different “acidic stimuli,” such as: (A.)
Hypercapnic Acidosis: rise in PCO2 with a concomitant decrease in extracellular pH;
(B). Isohydric Hypercapnia: proportional increase in both PCO2 and extracellular
[HCO3-] with maintained extracellular pH; and (C). Isocapnic Acidosis: decrease in
extracellular pH and [HCO3-] at constant PCO2. These “acidic stimuli” have been shown
to elevate intracellular calcium, [Ca2+]i, in isolated rat type I cells resulting in decreased
intracellular pH, (pHi), suggesting intracellular acidosis is responsible for inducing a rise
in [Ca2+]i (Buckler & Vaughan-Jones, 1994a).

Decreases in pHi cause the cells to

depolarize via K+ channel inhibition, resulting in voltage-gated Ca2+ influx. Support for
this model has been shown with evidence that acidosis inhibits whole-cell K+ currents in
type I cells (Peers, 1990b; Stea et. al., 1991; Buckler & Vaughan-Jones, 1993).
Additionally, Peers and Green (1991) indicated that an increase in pHi selectively inhibits
Ca2+-activated K+ currents in CB type I cells of neonatal rats.
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Past studies have

suggested that a fall in pHi may lead to Ca2+ entry through activation of the Na+-H+
exchanger, which would lead to a rise in intracellular Na+ ([Na+]i) and Ca2+ entry via a
Na+-Ca2+ exchanger. However, in the absence of extracellular Na+, [Na+]o, there was no
significant effect on resting levels of [Ca2+]i. In addition, when [Na+]o was removed and
type I cells underwent depolarization/repolarization steps from -60mV to 0mV and back,
recovery of [Ca2+]i was indeed slower in the absence of extracellular Na+. However, the
effect was quite small and therefore indicates that if Na+-Ca2+ exchanger is present it
likely plays only a minor role in the homeostasis of [Ca2+]i. Therefore, it seems as if the
response of the carotid body to changes in pH and CO2 is not dependent upon specialized
mechanisms for proton-extrusion, instead it is mediated through changes in the
relationship between pHi and pHo of type I cells (Buckler et. al., 1991).
In addition to the relationship between pHi and pHo, it is believed that TASK
channels, also known as, acid (or alkali) sensitive K+-channels of the tandem P-domain
K+-channel family, take part in CO2-sensing within the type I cells of the CB. These pHsensitive K+-channels are found in the brainstem neurons (Bayliss et. al., 2001; Duprat et.
al., 1997) as well as the glomus cells of the carotid bodies (Buckler et. al., 2000). TASK
channels belong to two main groups based upon structure and sequence homology, one
group consists of TASK-1, TASK-3 and TASK-5 and the other TASK-2,
TASK4/TALK2 and TALK 1 (Buckler et. al., 2007). Out of all the TASK channels, the
CB seems to have ones most similar to that of TASK-1 and TASK-3. Buckler, et. al.,
(2000), has shown that in rat carotid body type I cells, brief pulses of isocapnic acidosis
resulted in inhibition of the TASK-1 channels causing cell depolarization evoking a rapid
increase in intracellular calcium levels.

Oxygen sensitivity of the current was also
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decreased by the acidosis. Further work done by Kim et. al., (2009) demonstrated that in
rat carotid body type I cells, the predominant oxygen-sensitive TASK-like current is
carried by a heteromultimer of TASK-1 and TASK-3. These data lend further support to
data published by Buckler et. al., (2007) wherein channel activity of the TASK-like K+
channels were inhibited by reducing pHo. Data published from Trapp et. al., (2008) using
TASK-1-/-, TASK-3-/-, and TASK-1/3 double knockout mice, showed that TASK-1 and
not TASK-3 channels play a role in cell depolarization, calcium influx, and
neurotransmitter release during a hypercapnic event in mice carotid body type I cells.

Oxygen Sensing
Hypoxia stimulates neurotransmitter release from type I cells which leads to an
increase in CSN firing rate and results in a change in ventilatory pattern until
physiological PO2 levels are re-established and maintained. Results from many studies
suggest that hypoxic chemotransduction occurs through the inhibition of O2-sensitive K+
channels present in the type I cells (Lopez-Barneo et. al., 1988; Peers, 1990; Stea &
Nurse, 1991; Buckler, 1997).

Potassium channel inhibition causes type I cells to

depolarize allowing voltage-gated Ca2+ entry and NT release (Buckler & Vaughan-Jones,
1994b; Ureña et. al., 1994). The specific mechanism(s) by which K+ channels are
inhibited via hypoxia in carotid body type I cells are still being examined and are the
focus of this dissertation. While the precise oxygen-sensing mechanism(s) still remain to
be fully defined, two main hypotheses have been proposed: the Membrane and the
Mitochondrial hypotheses.
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Membrane Hypothesis
According to the membrane hypothesis, hypoxia suppresses K+ channels,
resulting in depolarization of the membrane, Ca2+ influx, and cytosolic Ca2+ increase
(Lopez-Barneo et. al., 1988; Buckler & Vaughan-Jones, 1994b). If hypoxia is coupled to
K+ channel inhibition through a membrane-delimited mechanism, this should be evident
and maintained in an excised patch of membrane. Necessary elements required for the
channels to be maintained should be found in the removed portion. This has been
demonstrated in certain experiments using adult rats (Riesco-Fagundo et. al., 2001),
whereas in other experiments using neonatal rats, hypoxic inhibition was no longer
maintained after excision (Wyatt & Peers, 1995). If chemotransduction following a
hypoxic exposure were truly a membrane-delimited process, then sensitivity to hypoxia
should be maintained in the patch for a period of time following excision. Elements
necessary for O2-sensing need to be tightly adhered to the cell membrane otherwise they
may be lost to the intracellular solution, resulting in attenuation of the cell’s oxygensensing ability (William & Buckler, 2004).

Studies have illustrated ‘run down’ in

activity of O2-sensitive K+ channel activity in rat type I cells when excised; however after
ATP was added to the intracellular solution, channel activity recovered.

Recovery

suggests that intracellular factors were necessary for O2-sensitive K+ channel activity and
the potential for metabolic regulation (William & Buckler, 2004; Varas et. al., 2007). In
favor of the “membrane” hypothesis, Williams et. al., (2004) proposed that O2-sensing
via the Ca2+-sensitive K+ (BKCa) channels in the rat CB is mediated via O2-sensitive
dependent carbon monoxide production via heme oxygenase-2 (HO-2).

Heme

oxygenase-2 is an enzyme, which in the presence of nicotinamide adenine dinucleotide
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phosphate (NADPH) and molecular oxygen (O2), catalyzes the breakdown of celluar
heme producing carbon monoxide (CO), iron, and biliverdin (BV) (Figure 2), which can
be broken down further into bilirubin by BV reductase (Williams et. al., 2004). Evidence
has emerged over the last 10-15 years suggesting that HO-2 may act as an O2 sensor
through the production of CO, which is a BKCa channel activator (Lopez-Barneo et. al.,
2008). It is believed that two K+ channels, Twik-related acid sensing K+ channels
(TASK-like) and BKCa channels, may play a role in the hypoxic depolarization of type I
cells of the rat (Buckler, 1997). Work done by Riesco-Fagundo et.al., (2001) and
Williams et. al., (2004) have shown that under normoxic conditions HO-2 in the presence
of CO, elicits an excitatory response on nearby BKCa channels assuring the channels
remain open. While under hypoxia, no excitatory response is observed, likely because
reduced CO levels combined with direct heme-dependent inhibition leads to K+ channel
closure, further supporting the role of HO-2 to K+ channel activation.
As BKCa channels are regulated by CO and/or NADPH cofactors, it is believed
that HO-2 functions as an acute O2-sensor in rat type I cells via regulation of BKCa
channel activity through the changing balance between intracellular concentrations of
HO-2 and the production of CO. However, to date, no assessment has been made to
outline the requirements necessary for hypoxic chemotransduction to occur within an
intact rat carotid body (Williams et. al., 2004; Kemp, 2005; Lopez-Barneo et. al., 2008).
The proposal of HO-2 acting as an O2 sensor has been challenged by experiments
conducted in HO-2 knockout (KO) mice. Oretga-Saenz et. al., (2006) have demonstrated
that HO-2 KO mice show no impairment in their hypoxic chemotransduction capacity.
Oxygen sensing in KO mice was not different from wild type (WT) mice when exposed
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Figure 2. Proposed model for inhibition of BKCa channel during hypoxia.
Under normoxic conditions, cellular heme is broken down into biliverdin, iron, and
carbon monoxide. Carbon monoxide is a (+) channel activator and makes certain the
BKCa channel is open during normal oxygen levels. During hypoxic conditions, the
availability of O2 becomes limited and heme is no longer produced and CO production is
greatly reduced.

The reduction in CO along with possible direct heme-dependent

inhibition (-) leads to channel closure (Modified from Kemp, 2005).

11

Figure 2.
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to varying levels of hypoxia. No differences were detected in dose-response curves from
glomus cells between KO and WT mice. These data suggest that the heme-oxygenase
hypothesis cannot be fully supported, and the mechanisms outlined in the membrane
hypothesis are not likely mediating O2-sensing within type I cells of the carotid body.
Even though BKCa channels in mice are not O2-sensitive (Wyatt & Evans, 2007), the
Oretga-Saenz data are still able to demonstrate that HO-2 does not play a role in hypoxic
inhibition of oxygen-sensitive delayed rectifier Kv channels in type I cells of mice carotid
bodies or indeed any K+ channels.

Mitochondrial Hypothesis
The mitochondrial hypothesis was first suggested after Heyman’s Nobel Prize
winning experiments demonstrated a possible role for the mitochondria in hypoxic
chemotransduction by the carotid body. Heyman’s use of potassium cyanide produced
similar effects to that of hypoxia in the carotid body (Heymans et. al., 1931), and later
other investigators demonstrated that cyanide inhibited the mitochondrial oxidase
cytochrome C (Wainio & Greenless, 1960; Van Buren et. al., 1972). It is also known that
physiological levels of hypoxia (20-60 mmHg) excite the carotid body (Lahiri et. al.,
1993) whereas in other cells that do not monitor oxygen levels, such as the dorsal root
ganglion, PO2 levels must fall below 5 mmHg before oxidation of NADH is shown to
accompany an increase in impulse discharge (Duchen & Biscoe 1992a, b; Jöbis, 1964).
Thus, together with the fact that mitochondrial inhibitors and uncouplers increase carotid
body activity, mimicking the effects of hypoxia (Krylov & Anichkov, 1968), these
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studies have led to the hypothesis that O2-sensing by the CB type I cells may be possible
through a mitochondrial cytochrome that has an unusually low O2-affinity (Mills &
Jöbsis 1970, 1972).
Further support for a role of the mitochondria in O2-sensing has been shown by
Mulligan et. al., (1981), whose work with oligomycin, which acts by binding ATPase in
such a way as to block the proton channel causing inhibition of oxidative phosphorylation
of ADP, demonstrated that intact oxidative phosphorylation is necessary for O2
chemoreception to occur. In addition, Mulligan’s work also reported that oligomycin
stimulates the CB chemoreceptor afferents and inhibits their response to further changes
in arterial PO2. These data suggest that mitochondrial inhibitors not only mimic hypoxia
but they stop further hypoxic effects at the cellular level. Buckler and Vaughan-Jones
(1998) also demonstrated that both hypoxia and mitochondrial uncouplers inhibit
background K+ currents suggesting that the same channels may be involved in eliciting a
response to both stimuli.

Additionally, Wyatt and Buckler (2004) showed that

mitochondrial inhibitors such as rotenone, cyanide, myxothiazol and oligomycin mimic
the effects of hypoxia by inhibiting background K+ currents, which led to membrane
depolarization and voltage-gated calcium entry. Further work in this paper has also
shown that in the presence of cyanide, rotenone or the mitochondrial uncoupler ptrifluorometoxyphenyl hydrazone (FCCP), further excitation of isolated carotid body type
I cells during hypoxia was prevented. These results suggest that the mitochondria, does
indeed play some role in O2-sensing by type I cells of the carotid body.
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ATP in Hypoxic Chemotransduction
Rat type I cells express background K+ channels that have biophysical and
pharmacological properties resembling the TASK group of tandem-p domain K+ channels
(Buckler, 1997; Buckler et. al., 2000). The channels are active over a wide range of
membrane potentials and are found to be the predominant K+ conductance at the resting
membrane potential of isolated type I cells.

It is thought that modulation of the

background K+ currents within type I cells is an important event in the process of
chemotransduction during hypoxia and/or acidosis. Background K+ currents have also
been shown to be sensitive to mitochondrial metabolic inhibitors (Wyatt & Buckler,
2004).

Inhibiting cellular metabolism results in decreased background K+ currents,

which leads to membrane depolarization, voltage-gated Ca2+ entry and NT release
(Buckler & Vaughan-Jones, 1998; Wyatt & Buckler, 2004; Varas et. al., 2007). Previous
studies have also shown that the response of these channels to hypoxic stimuli is absent
when mitochondrial function is inhibited, suggesting a strong relationship between O2sensing and energy metabolism.

Williams and Buckler (2004) have shown that

background K+ channel activity in excised membrane patches is enhanced in the presence
of millimolar levels of ATP. Further experimentation showed strong modulation of type
I cell background K+ currents in excised inside-out patches in the presence of MgATP as
well as other nucleotides such as, GTP, UTP, AMP-PCP and ATP-γ-S; indicating a
possible tie between energy metabolism and cell excitability that is mediated via
alterations in cytosolic, or sub-membrane levels of ATP (Varas et. al., 2007). This work
is in agreement with previous studies which have illustrated that excitation of type I cells
through inhibition of background K+ channels, membrane depolarization, voltage-gated
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Ca2+ entry and NT release is tied to mitochondrial metabolism (Williams & Buckler,
2004). It is possible there may be a link between changes in cytosolic ATP levels, the
activity of background K+ channels and mitochondrial energy metabolism. However, it
still remains to be determined if inhibition of mitochondrial energy metabolism results in
significant changes in cytosolic ATP in type I cells (Wyatt & Buckler, 2004). Multiple
nucleotides can activate background K+ channel activity (Varas et.al., 2007); therefore
there may be other pathways that may also link mitochondrial energy metabolism to type
I cell excitation.
Thus far it seems as if no consensus can be made regarding which hypothesis, the
mitochondrial or membrane, actually plays a role in O2-sensing. However, recent work
indicates that the “energy-sensing’ enzyme, AMP-activated protein kinase (AMPK), may
be a critically important kinase in the signal transduction cascade that couples the
mitochondria to excitatory events in the type I cell plasma membrane (Evans et.al., 2005;
Wyatt & Evans, 2007;Wyatt et.al., 2007; Evans et.al., 2009).

AMPK Hypothesis
Evidence suggests that physiological levels of hypoxia inhibits oxidative
phosphorylation of mitochondria in type I cells (Mills & Jöbsis, 1970, 1972; Duchen &
Biscoe, 1992a), which in turn causes an increase in the cellular ratio of ADP/ATP
(Figure 3). Adenylate kinase converts two molecules of ADP to AMP and ATP to
maintain ATP levels within the cell (Hardie & Hawley, 2001). The consequent increase
in AMP/ATP (Hardie & Hawley, 2001) activates AMPK, which has been reported to
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Figure 3.

Proposed mechanism by which hypoxic inhibition of mitochondrial

oxidative phosphorylation couples to type I cell depolarization and neurotransmitter
release by activation of AMP-activated protein kinase (AMPK).

Arrows in red

indicate inhibition. Hypoxia (<60 mm Hg) inhibits oxidative phosphorylation of the
mitochondria in type I cells, which leads to an increase in cellular ratios of ADP/ATP.
Adenylate kinase converts two molecules of ADP into ATP and AMP in order to
maintain ATP levels within the cell. Increased AMP/ATP ratio activates AMPK, which
has been reported to inhibit oxygen sensitive potassium channels leading to
depolarization of type I cells. Depolarization of the cells activates voltage-gated Ca2+
channels triggering an influx of calcium, release of neurotransmitters and an increase in
the firing of the carotid sinus nerve.
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Figure 3.
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inhibit oxygen sensitive potassium channels causing a depolarization of type I cells
(Evans et. al., 2005; Wyatt et. al., 2007; Ross et. al., 2011). The depolarization activates
voltage-gated

Ca2+

channels

triggering

calcium

influx

and

the

release

of

neurotransmitters, causing an increase firing of the carotid sinus nerve (Wyatt et. al.,
2007). This cascade of events suggests that AMPK can couple hypoxic inhibition of
oxidative phosphorylation to transduction of membrane-restricted events in type I cells,
which lends support to the mitochondrial hypothesis. The cascade of events is the basic
principle behind the AMPK transduction hypothesis (Figure 3). This dissertation will
test the hypothesis that AMPK couples hypoxic inhibition of oxidative phosphorylation
to mouse type I cell excitation and therefore plays a key role in hypoxic
chemotransduction by the carotid body and thus the acute hypoxic ventilatory response.
AMPK α1 and AMPK α2 knockout mice (Jorgensen et.al., 2004; Viollet et.al., 2003b)
will be used to examine this hypothesis.

AMPK Structure and Function
AMPK, is a serine/threonine protein kinase that forms a heterotrimeric complex
made up of an α catalytic subunit and 2 regulatory subunits, β and γ (Hardie, 2007).
Each subunit can occur as an alternate isoform that is encoded by 2 or 3 genes (α1, α2,
β1, β2, γ1, γ2, and γ3) and there are at least 12 different heterotrimer combinations
possible from the various isoforms (Hardie & Hawley, 2001). All 12 of the isoform
combinations are capable of forming a complex (Hardie et. al., 2003) and diversity of
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AMPK complexes occurs with alternative splicing and/or use of different promoters
(Hardie, 2004).
The N-terminus of the α subunit contains a conventional kinase domain (Figure
4a), while the C-terminal end is necessary to form a complex with the β and γ subunits
(Hardie, 2004). It appears there are distinct physiological differences between the α1 and
α2 subunits (Violett et.al., 2003 b; Jorgensen et.al., 2004).

For example, it has been

shown that mice lacking the α1 isoform of AMPK show no defect in glucose
homeostasis, illustrated by a glucose tolerance test (B. Viollet and F Andreelli,
unpublished data). The α1-/- mice also show a normal response to insulin and AICAR
(Jorgensen et.al., 2004). By contrast, mice lacking the AMPK α2 isoform exhibit glucose
intolerance and reduced sensitivity to insulin as well as AICAR-resistant (Jorgensen et.
al., 2004; Viollet et.al, 2003b). It has also been proposed that the AMPK α2 isoform but
not the AMPK α1 isoform plays a major role in controlling skeletal muscle metabolism
(Viollet et. al., 2003b).
In all eukaryotes, the β subunit (Figure 4b) is made up of an N-terminal region
that is followed by two regions, originally named the kinase interacting sequence (KIS)
and association with SNF1 kinase (ASC) domains (Jiang & Carlson, 1997). It was first
thought the KIS domain was necessary for interaction with the α subunit, while the ASC
domain interacted with the γ subunit. However, it has been shown that only the ASC
domain is necessary to give an active αβγ complex and the KIS domain is actually a
glycogen-binding domain (GBD) (Hardie et. al., 2003; Hardie, 2004). Each domain
binds ATP with a lower affinity than AMP and the binding of ATP and AMP is mutually
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Figure 4. Basic domain structure of the α, β, and γ subunits of AMP-activated
protein kinase (AMPK). A. Schematic of AMPK α subunit indicating the kinase
region, the site of phosphorylation by upstream kinases and the site for auxiliary subunit
binding. B. Schematic of AMPK β subunit indicating possible glycogen binding domain
and the site for αγ subunit binding. C. Schematic of AMPK γ subunit indicating the
crystathionine β-synthase (CBS) regions that form the two AMP/ATP binding ‘Bateman’
domains (Modified from Hardie, et.al., 2003).
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Figure 4.
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exclusive, thus when ATP levels are high activation of AMPK will not occur (Hardie,
2004, 2005). Activation of AMPK in mammals can occur via stressors such as hypoxia,
heat shock, lack of nutrients, oxidative stress or metabolic poisoning (Hardie & Hawley,
2001; Hardie, 2004).

Stress activation of AMPK results in a reduction in ATP

consumption and promotes ATP production.
AMPK is allosterically activated via 5’-AMP (Figure 5) but must be
phosphorylated by 1 or more upstream kinases, such as LKB1 or calmodulin-dependent
kinase kinasae β (CaMKKβ), at a threonine residue (Thr-172) within the α subunit kinase
activation loop (Hardie et. al., 2005). The most important AMPK upstream kinase
appears to be LKB1 (Hawley et. al., 2003) because it is constitutively active.
Phosphorylation of the Thr-172 residue within the α subunit, results in more than a 100fold increase in AMPK activation. Binding of AMP to the 2 Bateman domains of the
AMPK γ subunit (Scott et. al., 2004; Xiao et. al., 2007) activates the kinase by inhibiting
the de-phosphorylation of Thr-172 (Sanders et. al., 2007), causing a switch to the active
phosphorylated form. Further allosteric activation, of the phosphorylated AMPK, by up
to 10-fold, occurs when AMP binds to the γ subunit, thus the combination of the two
events leads to an increase in activation of about 1000-fold (Suter et. al., 2006, Evans
et.al., 2009). ATP, AMP and ADP compete for the two sites on the γ subunit, and under
normal physiological conditions ATP binds the inactive form of AMPK (Xiao et. al.,
2007). The bound inactive form is more abundant versus the AMP bound active form
(Evans et. al., 2009). The AMPK activation mechanisms ensure it is highly
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Figure 5. Schematic illustrating activation of AMP-activated protein kinase
(AMPK) via upstream kinases and AMP binding. AMPK is activated more than 100fold through phosphorylation at the Thr-172 residue on the α subunit via an upstream
kinase such as LKB1 or calcium/calmodulin-dependent protein kinase kinase beta
(CamKKβ). LKB1 constitutively phosphorylates Thr-172 but binding of AMP to 2
exchangeable sites on the γ subunits of AMPK also activates the kinase through
inhibiting the de-phosphorylation of Thr-172.

AMPK is now switched to its

phosphorylated form. Binding of the AMP to the γ subunits results in further allosteric
activation of the phosphorylated kinase by up to 10-fold, thus between the two events
there can be up to a 1000-fold increase in activation. Once AMPK is active it can
phosphorylate its target protein. AMPK is turned off by increasing levels of ATP.
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metabolically sensitive and even small changes in the ADP/ATP ratio can allow for
AMPK activation without a large decrease in ATP levels (Hardie & Hawley, 2001).
As previously mentioned, the most important upstream kinase, which plays a role
in AMPK activation, is the tumor suppressor, LKB1 (Hawley et.al., 2003). LKB1 is a 50
kDa serine/threonine kinase and inactivating mutations in LKB1 result in a dominantly
inherited cancer in humans known as Peutz-Jeghers syndrome (Woods et. al., 2003;
Shaw et. al., 2004). LKB1 exists as a heterotrimeric complex with two accessory
subunits, Ste20-related adaptor protein-α (STRADα) and mouse protein 25-α (MO25α)
(Hawley et. al., 2003; Boudeau et. al., 2004).
The two accessory proteins each have a closely related isoform, STRADβ and
MO25β. STRAD has a kinase-like domain that is related to the Ste20 protein kinase,
however it is classified as a pseudokinase because it lacks certain residues found in active
protein kinases (Baas et. al., 2003; Hawley et. al., 2003). The complex,
LKB1:STRAD:MO25, is only catalytically active when STRADα or STRADβ and
MO25α or MO25β are available to form the heterotrimeric complex (Hawley et. al.,
2003; Boudeau et. al., 2004). LKB1 appears to constitutively phosphorylate the Thr-172
residue thereby activating AMPK (Hawley et. al., 2003; Shaw et. al., 2004). Binding of
STRAD to LKB1 is required for LKB1 to phosphorylate AMPK and is also required to
anchor LKB1 to the cytoplasm. MO25 is necessary for stabilization of the
LKB1:STRAD complex (Hardie, 2005).
In addition to stressors, AMPK in many cells can also be activated via a Ca2+mediated pathway (Hawley et. al., 2005).

Stimuli, which lead to an increase in

cytoplasmic Ca2+, result in the activation of the calmodulin-dependent protein kinase
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(CaMKKβ). CaMKKβ is an upstream kinase of AMPK and activation of CaMKKβ
activates AMPK by phosphorylating the Thr-172 residue independent of AMP (Hawley
et. al., 2005).

Work done by Woods et. al. (2005) provides strong evidence that

intracellular Ca2+ acts as a second signaling pathway to activate AMPK. Instances that
lead to an increase in calcium may result in ATP depletion because the Ca2+ pump(s) no
longer have the energy needed to remove excess Ca2+ from the cytosol (Brini & Carafoli,
2009). Conditions that activate AMPK through an increase in the AMP:ATP ratio also
lead to an increase in intracellular Ca2+, i.e. oxidative stress, mitochondrial uncouplers,
and exercise in muscle (Patel et. al., 2001). As a result, it is therefore possible that
activation of AMPK may be a consequence of both ATP and Ca2+ mediated effects
involving both LKB1 and CaMKKβ (Woods et. al., 2005).

Pharmacological Manipulation of AMPK
Most data collected thus far with regard to the actions of AMPK has been
obtained using pharmacological tools, such as the putative antagonist Compound C.
However, it has been demonstrated that Compound C has off target effects, which are
independent of AMPK inhibition (Emerling et. al., 2007). Compund C has been shown
to not only inhibit AMPK but also many other protein kinases (Bain et.al., 2007). Many
experiments have also used the AMPK agonist, 5-aminoimidazole-4-carboxamide ribose
(AICAR). AICAR is taken up into the cells and converted to the AMP mimetic ZMP
(AICAR monophosphate) and is able to activate AMPK without affecting the AMP:ATP
ratio (Hardie et. al., 2003). However, recent experiments utilizing AICAR have shown
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that it may act as an inhibitor of Complex I of the mitochondrial electron transport chain
(Guigas et. al., 2007), which affects cellular energetics by decreasing the synthesis of
ATP and thus affecting the AMP:ATP ratio. In addition, it is not always possible to
differentiate between the specific actions of each of the catalytic subunit(s) through the
use of drugs alone. Activation of both AMPK α1 and AMPK α2 subunits may occur
when using AICAR, thus it is not possible to determine the action(s) of the specific
subunit(s) (Viollet et.al, 2003a). Therefore, it is of great importance to be able to
examine not only the role AMPK plays but also those subunit(s) combinations, which are
being activated to get a better idea as to how the kinase functions in regards to the role it
plays in hypoxia. In order to gain further insight into the role of AMPK α1 and AMPK
α2 subunits, research in this dissertation will focus on global AMPK α1 and global
AMPK α2 knockout mice as well as targeted AMPK α2 knockout mice.

Summary of Oxygen Sensing
To summarize, type I cells of the CB are the peripheral arterial chemoreceptors,
which are activated not only by hypoxia, but also hypercapnia and extracellular acidosis.
It has been known for over 70 years that the carotid body is an acute oxygen sensor and
within the past 10-15 years or so it has been shown that the CB contains several classes
of O2-sensitive K+ channels. Inhibition of these channels leads to depolarization of type I
cells, which allows entry of voltage-gated Ca2+ and NT release (Buckler & VaughanJones, 1994a; Peers & Buckler, 1995; Lopez-Barneo et. al., 2001). However, the exact
mechanism(s) which inhibits K+ channels during hypoxia in type I cells remains
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controversial.

Recently, AMP-activated protein kinase has been identified as a

potentially critical kinase in the transduction of hypoxic stimuli in carotid body type I
cells.

Clinical Relevance
Sudden infant death syndrome (SIDS) is the number one leading cause of death in
infants from 1 month to 1 year of age (Gauda et. al., 2007). Carotid bodies are the key
defense players in eliciting responses against hypoxia and hypercapnia.

Therefore,

possible exposure to oxygen extremes before birth may result in an ineffective response
by the PAC’s when faced with a hypoxic or hypercapnic event. This may predispose a
preterm infant to a higher risk of SIDS (Gauda et. al., 2007). Thus, basic research into
the mechanisms behind hypoxic chemotransduction and how carotid bodies are able to
respond to hypoxia may prove beneficial for successful therapies and/or strategies for
treatment of this disorder. This information may also prove beneficial to other disorders,
which are a result of prolonged or intermittent periods of hypoxia such as hypertension
and sleep apnea (Prabhakar et. al., 2005).
Research laid out in this dissertation utilized global and targeted knockout mice to
determine if and how the hypoxic ventilatory response (HVR) was altered when AMPK
α1 or AMPK α2 subunits were knocked out. If AMPK is important in oxygen-sensing in
the type I cells of the carotid body, knocking out of the catalytic subunit(s) may result in
an attenuation or complete lack of ventilatory response to hypoxia.
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Hypothesis: AMP-activated protein kinase (AMPK) couples hypoxic inhibition of
oxidative phosphorylation to type I cell excitation and therefore plays a key role in
hypoxic chemotransduction by the carotid body and thus the acute hypoxic
ventilatory response (HVR).

Specific Aims:
Specific Aim 1. Generate global knockout AMPK α1 and AMPK α2 mice as well as
generate mice with targeted AMPK α2 subunits knocked out in tyrosine hydroxylase
(TH) containing tissues, including the carotid body.

Specific Aim 2. Test the hypothesis that AMPK is required for a complete hypoxic
ventilatory response in mice using two-chamber plethysmography.

Specific Aim 3. Test the hypothesis whether knocking out of AMPK alpha subunits
modulates calcium signaling in mouse carotid body type I cells.
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Research Design and Methods

Global Knockout Mice
In the early 1980’s scientists, Martin Evan, Oliver Smithies and Mario Capecchi
developed the generation of a genetic “knockout” mouse (Thomas & Capecchi, 1987;
Doetschman et.al., 1987; Waldman, 1992). This breakthrough technology was the first
of its kind to allow replacement or disruption of a specific gene using an inactive or
mutated allele. Knockout mice allow scientists to selectively knockout or disable a
specific targeted gene in embryonic cells, which allowed them to study the effect of the
knocked out gene.

By the late 80’s, early 90’s, a “knock-in” mouse was finally

developed in order to examine the effects of a mutated DNA sequence that is exchanged
for an endogenous sequence without further disruption of the gene (Thomas et.al., 1986;
Capecchi, 1994). Knockout mice are valuable tools used today in various facets of
biomedical and pharmaceutical research. The research in this dissertation employed the
use of knockout mice by utilizing mice with either the AMPK α1 or α2 subunits knocked
out throughout the entire mouse because simultaneous knockout of both subunits is
embryonic lethal (Viollet, et. al., 2003b).

The global AMPK α1 knockout mouse

(AMPKα1-/-) used in experiments is designated B6.129/Sv-Prkaa1tm1Sbj/Orl, it is a knockin of beta-galactosidase/Neomycin (=GEO) gene fusion.

In order to inactivate the

AMPK α1 catalytic domain, a replacement vector was made with 7kb of ES-129-derived
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genomic fragment and a selection cassette, which deleted part of the catalytic AMPKα1
subunit from amino acids 97-157 (Jorgensen et. al., 2004) (Figure 6).

The global

AMPK α2 KO mice (AMPK α2-/-) are designated B6.129/Sv-Prkaa2tm1.1Vio/Orl, and were
obtained from a conditional knockout (alpha2 floxed mouse) crossed with an Ella-Cre
deleter mouse. The AMPK α2 genomic clones were isolated after screening a mouse 129
strain genomic library (Stratagene, La Jolla, CA). The targeting construct was produced
by flanking exon C, which encodes the AMPK α2 catalytic subunit with loxP sites for
Cre recombinase and inserting a phosphoglycerol kinase (PGK) promoter-driven
neomycin selection cassette that was flanked by an additional loxP site (Viollet et.al.,
2003b) (Figure 7). The targeted construct was linearized and electroporated into 129/Sv
MPI-I embryonic stems cells. Cells expanded from the targeted clones were injected into
C57BL/6 mice. The heterozygous offspring were then bred with a “deleter” Ella-Cre
transgenic mouse, in which Cre was expressed in the the germline, to produce AMPK
α2+/- mice (Holzenberger et.al., 2000). These mice were used to confirm the role(s)
AMPK α1 and/or AMPK α2 subunits play in response to hypoxia by the carotid body.
The breeding plan for generating the global AMPK KO experimental animals is shown in
Figure 8a. PCR was used to confirm correct genotype for both global AMPKα1 and
AMPKα2 KO mice (Figure 8b). AMPK α1+/- and AMPK α2+/- mice were obtained from
the European Mutant Mouse Archive (EMMA) with the kind permission of Dr. B.
Viollet. These animals were bred onto a mixed C57BL/6J:129-1x background to provide
homogeneity with all the other knockout mice used in the Wyatt laboratory. AMPK α1+/and AMPK α2+/- mice were then bred to provide -/- mice and their +/+ controls.
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Figure 6.

Generation of AMPKα1 Knockout Mice. A schematic (not to scale)

illustrating the genomic structure of the AMPK α1 wildtype allele (top), the AMPKα1
gene-targeting construct that contains a promoterless IRES-βGeo cassette (middle), and
the targeted gene (bottom). E, EcoRI digestion; IRES, internal ribosomal entry site;
βGeo,

β-galactosidase

and

neomycin

phosphtransferase

polyadenylation sequence; hatched vertical bar, introns.
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fusion

gene;

pA,

Figure 6.
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Figure 7.

Generation of AMPKα2 Knockout mice.

Schematic (not to scale)

illustrating the genomic structure of the AMPK α2 wild-type allele, AMPK α2 genetargeting construct, AMPK α2 targeted allele, and AMPK α2 null allele.

Squares

indicate loxP sites and H’s indicate HindIII restriction sites. C, exon encoding the
AMPK α2 catalytic domain (amino acids 189-260).
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Figure 8. A. Global mouse breeding plan. Shown is the breeding plan to obtain global
AMPK α1 and AMPK α2 knockout mice for use in plethysmography and cellular
studies.
B. PCR bands for wild type, heterozygous and homozygous AMPK α1 and AMPK
α2 knockout mice. Gel confirms correct genotype for AMPK α1 KO and AMPK α2 KO
mice.
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Figure 8. (A)

Figure 8. (B)
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Mice were tail clipped at 5 days of age and genotyped as follows (all primer sequences
were obtained from Dr. B. Viollet) (Table 1).
AMPKα1 wildtype allele, forward: KO+ AGC ACA GTA CCT GGT ATC TTA
TAG G, reverse: KO- GGA CTT ATT ACT AAA CAG ACC TCT G (yields 329bp band
for WT allele). AMPKα1 deleted allele, forward: GEO+ ACC AGA AGC GGT GCC
GGA AAG CTG G, reverse: GEO- TGT AGT CGG TTT ATG CAG CAA CGA G
(yields 466bp band for deleted allele). Tail DNA and primers were added to GoTaq mix
(Promega) and PCR cycled as follows: 94°C, 4 min, 94°C, 45 sec, 35 cycles; 57°C, 45
sec, 35 cycles; 72°C, 60 sec, 35cycles; 72°C, 7 min; 4°C hold.
AMPKα2 wildtype allele, forward: loxF1 GCT TAG CAC GTT ACC CTG GAT
GG, reverse: loxR1 GTT ATC AGC CCA ACT AAT TAC AC (yields 200bp band for
WT allele). AMPKα2 deleted allele, forward: same as for WT, reverse: koTneoR GCA
TTG AAC CAC AGT CCT TCC TC (yields 600bp band for deleted allele). Tail DNA
and primers were added to GoTaq mix (Promega) and PCR cycled as follows: 94°C,
4min; 94°C, 20sec, 35 cycles; 58°C, 20sec, 35 cycles; 72°C, 30 sec, 35 cycles; 72°C, 7
min; 4°C hold.
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Table 1. Primers used for genomic PCR of global AMPK α1, AMPK α2, and THtargeted knockout mice shown with melting temperatures (TM) and amplicon size
(SIZE).
GENE

SEQUENCE

TM

SIZE

AMPKα1 KO-

5’GGACTTATTACTAAACAGACCTCTG 3’

94° C

329bp WT

AMPKα1 KO+

5’ AGCACAGTACCTGGTATCTTATAGG 3’

94° C

AMPKα1 GEO+

5’ACCAGAAGCGGTGCCGGAAAGCTGG 3’

94° C

AMPKα1 GEO-

5’ TGTAGTCGGTTTATGCAGCAACGAG 3’

94° C

TH-3 Reverse

5’ CTTTCCTTCCTTTATTGAGAT 3’

92° C

290bp WT

5’ GATACCTGGCCTGGTCTG 3’

92° C

430bp TH-Cre+/+

5’CACCCTGACCCAAGCACT 3’

92° C

AMPKα2 kOTneoR

5’ GCATTGAACCACAGTCCTTCCTC 3’

94° C

200bp WT

AMPKα2 LoxF1

5’ GCTTAGCACGTTACCCTGGATGG 3’

94° C

600bp AMPKα2-/-

5’ GTTATCAGCCCAACTAATTACAC 3’

94° C

AMPKα2 LoxF1

5’ GCTTAGCACGTTACCCTGGATGG 3’

94° C

200bp WT

AMPKα2 LoxR1

5’ GTTATCAGCCCAACTAATTACAC 3’

94° C

250bp floxed

CRE-UD

466bp AMPKα1-/-

TH-5 Forward

AMPKα2 LoxR1

200bp/250bp
heterozygous
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Targeted Knockout Mice
It is possible that globally knocking out AMPK α subunits may have an inhibitory
effect on the hypoxic ventilatory response via a mechanism mediated by something other
than the carotid body. Recent data reveal that AMPK has multiple ion channel targets
(Dallas et. al., 2009; Evans et. al., 2009; Kreneisz et. al., 2009) and by knocking out
AMPK in the brain, it may affect the path that signals from the carotid body and
integrates with the central mechanisms of ventilatory control. Thus, it is possible by
knocking out AMPK there may be alterations in central neuronal firing such that it could
directly modulate the mechanisms that pattern inspiration (Doi & Ramirez, 2008) in
addition to any CB mediated actions.

To minimize the possible central effects of

knocking out AMPK, experiments focused on targeting AMPK α2 knockout to neurons
containing tyrosine hydroxylase (TH). By targeting to dopaminergic and nor/adrenergic
neurons, AMPK α2 subunits were deleted from the carotid body type I cells but were
spared in much of the central processing hypoxic peripheral input (Gozal et.al., 2000;
Takakura et.al., 2006). However, some central TH containing neurons can modulate the
carotid body chemoreflex (Zhang & Mifflin, 2007; Viemari, 2008), thus caution would
be needed when interpreting the data.
As mentioned previously, to minimize the possible central effects of knocking out
AMPK, the experiments illustrated in this dissertation have focused on targeting AMPK
α2 knockout to neurons containing tyrosine hydroxylase. Tyrosine hydroxylase is the
rate-limiting enzyme in the biosynthesis of catecholamines (Lindeberg et. al., 2004).
Through targeting of dopaminergic and nor/adrenergic neurons, the AMPK α2 subunits
should be knocked out in the carotid body type I cells but remain untouched in much of
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the central processing of hypoxic peripheral input (Gozal et. al, 2000; Takakura et. al.,
2006). One area of the brain that may be affected by the knockout of AMPK α2 and is
believed to be involved in the hypoxic response includes the locus coeruleus (LC). The
LC is a cluster of noradrenaline containing neurons found adjacent to the fourth ventricle
in the pontine brainstem (Berridge and Waterhouse, 2003). It is the principle site for the
production of noradrenaline and has many projections that innervate almost all regions
within the central nervous system (CNS), which include the nuclei responsible for
thermoregulation and cardiorespiratory function (Bockstaele et. al., 1999). Evidence
suggests that excitation or inhibition of noradrenergic structures such as the LC can
modulate the cardiorespiratory responses to peripheral chemoreceptor activation
(Koshiya & Guyenet, 1994; Perez et.al., 1998). It is possible that by targeting AMPK
knockout to TH containing neurons the activity of the LC is changed and, in theory, this
could blunt the HVR (Zhang & Mifflin, 2007). However, work done by Biancardi et.al.,
(2010) used selective bilateral chemical lesions in the LC to demonstrate that under
hypoxic conditions, chemical lesions of the LC had no affect on minute ventilation, mean
arterial pressure, heart rate or core body temperature. Therefore they were able to show
that the noradrenergic neurons of the LC do not play a role in cardiorespiratory control
and thermoregulation during acute hypoxia.
Genetic manipulation through the use of the Cre-lox recombination system has
proven to be extremely beneficial in elucidating gene function in many experimental
organisms, especially mice (Le & Sauer, 2001). Through the use of the Cre-lox system it
is now possible to generate knockout and targeted knockout animals without causing
death. In many cases knocking out a certain gene can lead to embryonic death and thus
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result in an inability to acquire adult animals to study the effect of the gene later in life
(Sauer & Henderson, 1988; Holzenberger et. al., 2000; Le & Sauer, 2001). The Cre-lox
recombination makes it possible to study the effects of gene knockout in adult organisms
as well as the effects of a tissue specific gene knockout. Cre recombinase is a single 38
kDa protein necessary for the catalyzation of DNA recombination between two 34 base
pair loxP sites. Each loxP site contains two 13-basepair palindromes separated by an 8basepair spacer that confers directionality to the site. The region of DNA that is flanked
by the two loxP sites is said to be “floxed” (Le & Sauer, 2001). The loxP sites contain
specific sites for Cre binding, which surround a specific DNA sequence where
recombination may occur. Recombination occurs in cells that express Cre and contain
loxP sites. Cre recombinase cuts the double stranded DNA at the specified loxP sites and
the strands are then re-joined with DNA ligase (Sauer & Henderson, 1988).

The

sandwiching of DNA between the 2 loxP sites is termed “floxed,” which is a contraction
of “flanked by lox.” The use of a conditional targeted gene knockout mouse model
(Figure 9) has allowed for examination of the function of a specific gene in a targeted
tissue without affecting the expression of the gene in non-targeted tissue (Lindeberg et.
al., 2004).
In order to effectively target knockout of AMPK α2 activity in the carotid body,
mice conditional for the expression of floxed AMPK α2 were crossed with mice
expressing Cre recombinase under a TH promoter (B6;129X-1THtm(cre)Te/Kieg),
(Lindeberg et. al., 2004). Mice conditional for AMPK α2 allows for the specific gene to
be knocked out in a specific organ or tisssue versus the entire mouse. AMPK α2 should
be ablated in the catecholaminergic TH-expressing type I cells of the TH-Cre+/+FloxedFl/Fl
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Figure 9. Schematic illustrating TH-targeted AMPKα2 knockout to the carotid
body. The Cre mouse is under a tyrosine hydroxylase promoter and was crossed with a
LoxP (Floxed) mouse. The floxed mouse has the gene of interest, AMPK α2, flanked on
either side by a loxP site. When the TH-cre mouse is bred with the floxed mouse, cells
with active Cre recombinase cuts the double stranded DNA at the specified loxP sites and
the strands are then re-joined. Any cells containing tyrosine hydroxylase will have
AMPK α2 knocked out including the carotid body. Cells lacking active Cre recombinase
do not have AMPK α2 knocked out. Recombination occurs only in cells that express Cre
and contain both loxP sites. Cre recombination allows one to study the knockout of a
specific gene as well as the effects of a tissue specific gene knockout.
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mice (Figure 10). Lindeberg et. al., (2004), has been able to show the TH-Cre (B6;129X1THtm(cre)Te/Kieg) mice can be successfully crossed with a β-galactosidase (LacZ)
reporter strain wherein the reporter gene is activated via Cre recombination. The double
heterozygous offspring showed good correlation between LacZ expression and THexpressing cells illustrating efficient genomic recombination in the TH-expressing cells.
Therefore, crossing the AMPK α2 floxed mice with the TH-Cre mice should remove
AMPK α2 from TH-expressing cells including the carotid bodies. To increase the
efficiency of the targeted knockout of AMPK α2, F2 generation male TH-Cre+/+FloxedFl/mice (Figure 10) were crossed with female TH-Cre+/+FloxedFl/- mice. The F1 generation
mice from this cross are shown in Figure 11. This genotype should provide knockout of
the AMPK α2 subunits in the targeted TH-cells (Sakamoto et. al., 2005). By using the
refined breeding strategy illustrated in Figure 11, the percentage of viable experimental
mice increased to 100% by giving mice that are all homozygous for TH-Cre and either
homozygous or heterozygous for the flox gene. Mouse DNA genotyping via PCR was
done on tail clippings at 5 days of age and genotyped using specific primers for the Cre
transgene and floxed AMPK α2 (all primer sequences were obtained from Dr. B. Viollet
(Figure 12, Table 1)).
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Figure 10. Targeted knockout breeding strategy. Shown is the initial breeding plan to
obtain TH-targeted AMPK α2 knockout in the carotid body type I cells. Crossing the
heterozygous F1 generation results in a wide range of possible F2 genotypes.
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Figure 10.

*TH-Cre+/+FlxFl/Fl
*TH-Cre+/+FlxFl/-

Successful Target
Sucessful Target

*TH-Cre-/-FlxFl/Fl
*TH-Cre+/-FlxFl/-

Same as Fo (i.e. control)

*TH-Cre+/-FlxFl/*TH-Cre-/-FlxFl/-

Same as F1 (i.e. control)

*TH-Cre+/+Flx-/*TH-Cre+/-Flx-/-

Same as Fo (i.e. control)

*TH-Cre-/-Flx-/-

Wildtype (i.e. control)
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Figure 11. Refined targeted breeding strategy. The targeted breeding strategy shown
in Figure 10 will result in a low percent of TH-targeted AMPK α2 knockouts. Crossing
the F2 TH-Cre+/-FloxFl/- mice from Figure 10, will yield 100% experimentally viable
progeny.
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Figure 11.

All animals are useable for experimentation
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Figure 12.

PCR primer bands for TH-Cre and Floxed2.

genotype for TH-targeted knockout mice.
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Gel confirms correct

Figure 12.
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General Methods:

Plethysmography
Ventilatory in all wildtype, global AMPK α1 and AMPK α2 knockouts as well as
TH-targeted AMPK α2 KO mice was measured using pressure plethysmography
(Stunden et.al., 2001). All experiments were conducted at room temperature (22-24°C).
Each mouse was placed into a 100cc plexiglass Respiromax plethysmography chamber
(Figure 13) (Columbus Instruments, Columbus, OH). A tail rod moved the mouse
forward in the chamber securing it and preventing it from backing up. Mice were set in a
prone position allowing their snouts to emerge through an inflatable latex cuff into the
head chamber. The cuff was inflated (maximum 20 P.S.I.) giving an airtight seal around
the snout of the mouse. Pressure changes within the body chamber as a result of the
animals’ respiration were measured through a transducer and this signal was digitized at
200Hz data points per second using a Respiratory Function program (Columbus
Instruments, Columbus, OH). Information was displayed and stored in a computer for
statistical and graphical analysis. Oxygen flow passing into the head chamber was
controlled with a Pegas 4000 (MF) Gas Mixer and Gas Mixer System Software
(Columbus Instruments, Columbus, OH). Respiration rates (RR) and tidal volume (VT)
were measured in all wildtype, global and TH-targeted knockout mice using a Columbus
Instruments Tidal Volume Meter.
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Figure 13. Mouse two-chamber plethysmography unit. Schematic of Respiromax
two-chamber plethysmography unit indicating position of mouse and separate face and
body chambers.
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The head chamber was supplied with humidified 21% O2 and 0% CO2 gas mixture
(balanced Nitrogen) at a flow rate of ~0.8L/min to establish a baseline recording for 3
minutes. To obtain peak acute hypoxic responses, oxygen levels were decreased to 12%
or 8% for 3 minutes and then returned to 21% for a final 3 minutes. Respiration rates and
tidal volume data were monitored, collected and analyzed using the Respiromax/tidal
volume computer program, version 2.06. Data was taken from 40-50 seconds of stable
breathing during the peak response of each change in O2 level, 21%, 12%, 21% as well as
21%, 8%, 21%. In addition, data was taken from 40-50 seconds of stable breathing
during exposure to 0%, 7%, 0% CO2 at a flow rate of 1L/min for 2 minutes at each level.
Data containing artifacts caused by mouse movement were excluded from analysis. All
animals were awake during data acquisition and were weighed before testing (25-35
grams).

Isolation of Type I Cells
All cellular experiments were conducted using type I cells isolated and
enzymatically dissociated from the carotid bodies of mice. The carotid bifurcations of
the mouse were removed and the carotid bodies were isolated under a dissecting
microscope. Isolated CB’s were placed in ice-cold oxygenated phosphate buffered saline
(low Ca2+ and Mg2+). Carotid bodies were then placed into low Ca2+ and Mg2+ saline
with 0.040% collagenase Type I (22µ/mg, Worthington Biochemical Corporation) and
0.025% trypsin Type I (10100µ/mg, Sigma) and put into a 37°C incubator for 20 minutes
for dissociation. Carotid bodies were then teased apart using forceps and incubated for an
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additional 7 minutes. Cells were then centrifuged at 730 rpm (200g) for 5 minutes and
supernatant was removed. Cells were re-suspended in Hams F12 (Sigma) supplemented
with 10% fetal bovine serum (Biowest) and then centrifuged for an additional 5 minutes.
Type I cells were plated onto 10mm poly-d-lysine (Sigma) coated (0.1mg/ml) cover slips
and incubated for at least 2 hours to allow the type I cells to settle and stick to the cover
slips. Cells were used within 8 hours of isolation because cell viability greatly decreases
after this point in time.

Immunocytochemistry
Isolated type I cells for AMPKα2 +/+ or -/- were processed separately using the
same reagents. Cells were processed on the same day at the same time and every effort
was made to treat the two groups of tissue identically. Coverslips with attached type I
cells were fixed by immersion in methanol at -20° C for 20 minutes. Cells were then
permeablized by 3x5min washes with 0.3% triton X-100 (Sigma) in phosphate buffered
saline (PBS). Type I cells were given another 3x5min wash with blocking solution (1%
donkey serum, 0.3% triton X-100 in PBS) to limit non-specific binding of the specific
anti-AMPK α2 receptor antibodies. Anti-AMPK α2 1° antibodies (Kinasource, UK)
were diluted 1:750 with blocking solution, added to the coverslips and incubated at 4° C
for 16 hours. Cells were also stained with a rabbit anti-mouse tyrosine hydroxylase
antibody (1:2000, Sigma) to assist identification of type I cells. Following incubation
with the 1° antibodies, coverslips were washed 4x5min with blocking solution and then
incubated for 1 hour, at room temperature in the dark with 1:200 dilution of Rhodamine
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Red-X-conjugated affinipure donkey anti-rabbit IgG (Jackson Immunoresearch) and
FITC-conjugated

affinipure

donkey

anti-sheep

IgG

2°

antibody

(Jackson

Immunoresearch, 1:200). Coverslips were then washed for 5x5min with PBS before
being inverted and attached to microscope slides with hard setting anti-fade mountant
(2.4g Mowiol 4-88, 6g glycerol, 6ml H2O, 12ml 0.2M Tris buffer pH 8.5, 2,5%
diazobicyclo-octane) containing 4’, 6-diamidino-2-2-phenylindole dihydrochloride
(DAPI, 1mg ml-1) for visualization of type I cell nuclei. For controls, 1° antibody was
omitted during this procedure. Images were acquired using a DeltaVision microscope
system (Applied Precision) on an inverted Olympus IX71 microscope with an oil
immersion, x63 magnification, 1.4 n.a. objective and Coolsnap HQ CCD camera
(Photometrics). Multiple z-sections (focal depth 0.28 µm, z-step 0.25µm) were taken
through individual cells.

Images were deconvolved on-line via Softworx software

(Applied Precision). Deconvolved images of these identically processed cells were then
viewed using identical intensity parameters in Softworx and intensity line plots were
constructed by appending a line across the center of the cell of interest. Pixel intensity
was reported along the line and allowed comparisons between staining in AMPK α2+/+
and AMPK α2-/- type I cells (Figure 14).

Genomic Polymerase Chain Reaction
Genomic DNA was isolated from 5-7 day old tail tips using DNeasy® tissue kit
(Qiagen) according to manufacture’s instructions. Genomic polymerase chain reaction
(genomic PCR) analysis was performed using 1.0 µl of genomic DNA, 6.7 µl double
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Figure 14. AMPK α2 staining in mouse carotid body type I cells from wildtype and
AMPK α2 knockout mice. A. Staining in wildtype AMPK α2 mouse type I cell. Green
is AMPK α2 and blue is DAPI staining for the nucleus. The white scale bar is 10 µm and
the red line indicates the location of the intensity plot shown in panel C. B. Reduced
staining shown in AMPK α2 KO mice type I cells. Green is AMPK α2 and blue is DAPI
staining for nucleus. The red line indicates the location of the intensity plot shown in
panel C and D. C and D. Intensity line plots from panels A and B respectively. Data is
represented in thousands of units. Staining was done on AMPK α1 WT and KO mice
type I cells but was not successful. Lack of success in the AMPK α1 mice may have
been a result of the antibodies not working properly.
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distilled water, 1.6 µl of 10 µM Primer TH-5, 1.6 µl of 10 µM Primer TH-3, 1.6 µl of 10
µM Primer Cre-UD and 12.5 µl 2X GoTaq Green™ (Promega) mix. Genomic PCR was
performed as follows: a 5 minute denaturation step at 92°C, 35 cylces of 45 seconds at
92°C, 45 seconds of annealing at 56°C, and 1 minute extension at 72°C, followed by a
final extension for 7 minutes at 72°C. Genomic PCR products were separated on a 1.5%
agarose gel, and visualized using ethidium bromide and UV light. Images were captured
using a LAS-3000 Imager (Fuji) and Image Reader software.

Ca2+ Imaging
Isolated type I cells were loaded with Fura-2AM (5µM, Invitrogen) in an
extracellular solution containing (in mM): NaCl, 140; KCl, 4.5; CaCl2, 2.5;
MgCl2, 1.0; glucose, 11.0; HEPES, 20.0; pH 7.4 with NaOH, for 30 minutes, at room
temperature (22-24°C) in the dark. Fura-2AM, is a membrane permeable, dual
wavelength, fluorescent dye. Once inside the type I cells, the –AM portion of the dye is
cleaved off leaving behind the charged Fura-2, which is calcium-sensitive, and binds free
Ca2+ resulting in a change in its fluorescent properties. Cover slips with Fura-2 attached
loaded cells were washed with extracellular solution for 15 minutes before being
mounted in a chamber (0.4 ml) and perfused at 8 ml/min-1 with a standard bicarbonate
buffered solution (in mM; NaCl, 117; KCl, 4.5; CaCl2, 2.5; MgCl2, 1.0; glucose, 11.0;
NaHCO3, 23.0) gassed with 5% CO2 balanced air (35-37°C, pH 7.4). Cells were
visualized with a CFI super fluor 40x oil immersion objective. Fura-2 was excited with
50 ms exposures to 340nm and 380nm light at 0.2-0.5 Hz using a Lambda 10-3 filter
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wheel (Sutter) and emitted fluorescence measured at 470-550nm using a CoolSNAP HQ2
CCD camera. Neutral density filters of 0.7 optical densities were placed in the excitatory
light path to reduce any photodamage to cells (Burlon et.al., 2009). Data acquisition and
analysis was controlled using Metafluor 7.1.2. imaging software (Molecular Devices).
Only cells that maintained a low resting intracellular Ca2+ level and had a strong and
reversible increase in fluorescence ratio to 20% CO2 were used for further experiments.
The robust response signifies a healthy cell, which has not been damaged by enzyme
digestion (Burlon et. al., 2009; Thompson et. al., 2010; Thompson & Wyatt, 2011). Type
I cells were then exposed to a hypoxic solution (10 mm Hg/10 torr) and the ratio of
[Ca2]i was measured. Calcium ratio data was reported as a ratio instead of absolute
calcium values because the system could not be calibrated properly with ionomycin. In
order to properly calibrate for absolute calcium the following equation would be used:
[Ca]=Kd(Sf2/Sb2)(Rexp-Rmin/Rmax-Rexp) where Kd is the affinity of Fura-2 for calcium, Sf2
is the intensity at 380nm for calcium free, Sb2 is intensity at 380nm for bound calcium,
Rexp is measured experimental ratio, Rmin is 0 Ca ratio and Rmax is Ca saturated ratio. The
oxygen tension reached in the bath was measured using an OxyMicro oxygen sensor
(WPI). The level of hypoxia reached in the bath over one minute was 10 torr, which is a
level shown to excite the carotid body type I cells (Figure 15).

Metabolism
Basal metabolic rates (BMR) were assessed on all wildtype, global AMPK α1 and
AMPK α2 knockout mice. Oxygen consumption and carbon dioxide excretion were
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Figure 15. Recording Bath Oxygen Tension. Figure illustrates the oxygen level
reached in the bath for calcium-imaging experiments. The level of oxygen (~10 torr)
reached excites the type I cells. Experiments took place at a bath temperature of 37° C.
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measured with open flow respirometry using oxygen and carbon dioxide gas analyzers
(S-3A/I, Applied Technologies, Pittsburgh, PA, USA; CD-3A, Applied Technologies,
Pittsburgh, PA USA, respectively). Flow rate (0.248-0.257 L/min) was controlled with a
4100 Series flow meter (TSI Inc., Shoreview, MN). All mouse weights were noted before
.
.
trials began. VCO2 and VO2 were corrected as standard temperature and pressure under dry
conditions (STPD). Mice were placed in a 14cm x 10.2cm x 7.6cm plastic metabolic
chamber (Figure 16) and allowed to acclimate to their surroundings for 30 minutes
before the experiment began. All metabolic experiments were run for 30 minutes and
data were collected every 5 minutes unless there was a change of more than 0.05 in
consumed oxygen or excreted carbon dioxide and then data were collected and the time
point was noted. Chamber temperature and barometric pressure were measured for each
trial and were on average 27 ºC and 736 mmHg, respectively. Oxygen and carbon dioxide
analyzers were calibrated each day before experiments were run to ensure accurate
readings.

Data Analysis and Statistics
Values in figures and text are reported as means ± S.E.M. Significance was
determined where appropriate using unpaired Student’s t-Tests with P<0.05 defined as a
significant difference. Further statistical guidance will be sought from the Wright State
University Statistical Consulting Center.
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Figure 16. Schematic illustrating the metabolic chamber set up. A. Metabolic
chamber, B. Filter, C. Flow meter, D. Carbon dioxide analyzer with drying column, E.
Oxygen analyzer, F. Suction pump

66

Figure 16.

67

Results

Plethysmography
Ventilatory Response of Global AMPK α1 and AMPK α2 Knockout and THtargeted Knockout Mice to Hypoxia
It is well known that the carotid bodies respond to changes in the PO2 of the blood
and act to produce an increase in ventilatory response upon exposure to a hypoxic
situation (Heymans et.al., 1930). A two-chamber plethysmography unit was used to
determine the role of AMPK in the hypoxic response. Resting or baseline breathing rates
were examined first then mice were exposed to a hypoxic challenge. Figure 17 shows
the baseline breathing rates for all wildtype mice (n=9), global AMPK α1 knockout mice
(n=20) and global AMP α2 knockout mice (n=22). The frequency (f), or respiration rate,
in breaths/minute was not significantly different between the WT (269.66±17.23
breaths/min) and global knockout mice (α1KO, 253.91±14.10; α2KO 273.51±14.73
breaths/min) at rest (Figure 17, i.). There was no difference in tidal volume (VT, µl/g)
between the WT (7.12±0.90 µl/g) and global knockout α1 (6.38±0.34 µl/g) or α2
(6.82±0.61 µl/g) mice at rest (Figure 17, ii). In addition, at rest, minute ventilation (VE,
ml/min/g) was slightly attenuated in the AMPK α1 knockout mice (1.56±0.08 ml/min/g)
compared to the WT (1.91±0.24 ml/min/g) and AMPK α2 (1.84±0.15 ml/min/g) mice but
the difference was not significant. Upon exposure to 12% oxygen, the percent change
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Figure 17. Histograms showing baseline ventilatory responses in wildtype, AMPK
α1 and AMPK α2 knockout mice. (i.) Resting Breathing, (ii.) Tidal Volume, (iii.)
Minute ventilation at rest (WT, n= 9; AMPK α1-/-, n=20; AMPK α2-/-, n=22).
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in frequency, which is the difference in respiration rate between 12% O2 and 21% O2 was
not significantly different between the WT (8.62±2.04%) or α1 knockout mice
(9.21±2.26%). The AMPK α2 knockout mice (2.37±2.76%) showed a reduced percent
change in respiration rate but it was not significant due to wide variability (Figure 18, i).
Due to wide variability the percent change in tidal volume, difference in tidal volume at
12% O2 and 21% O2, showed no significant difference between the WT (2.32±8.29),
global α1 knockout (-1.74±4.18%) or AMPK α2 KO mice (2.75±3.12%) (Figure 18, ii).
Overall, there was no significant difference between the % increase in minute ventilation
seen with the WT, (11.53±10.29%) global AMPK α1, (6.34±3.56%) and AMPK α2
knockout (4.99±3.69%) mice during a 12% oxygen challenge (Figure 18, iii).
In order to determine the acute ventilatory response to a more severe hypoxic
challenge, baseline breathing rates were collected, then mice were exposed to 8%
oxygen, which corresponds to 25,000 feet (7620 meters) and is an extreme level of
hypoxia. Figure 19, illustrates the baseline breathing for the ventilatory response at rest
in the control (n=21) and global AMPK α1 knockout (n=33) mice before exposure to 8%
oxygen.

The frequency in breaths/minute between the WT (249.22±8.06 breaths/min)

and α1-/- mice (275.59±7.16 breaths/min) at rest was slightly elevated in the knockout
mice but was not significant (Figure 19, i). Tidal volumes of the WT (9.1±0.52 µl/g)
mice were slightly elevated at rest versus the AMPK α1 KO (6.4±0.34 µl/g) mice but
were not significant (Figure 19, ii).

Resting minute ventilation was significantly

attenuated in the global AMPK α1 KO (1.73±0.08 ml/min/g; unpaired
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Figure 18. Percent Increase in Breathing upon exposure to 12% O2. (i.) Percent
change in frequency (F), (ii.) Percent change in tidal volume (VT), (iii). Percent change
in minute ventilation (VE) in AMPK α1 and AMPK α2 KO mice when exposed to 12%
oxygen compared to WT (WT, n= 9; AMPK α1-/-, n=20; AMPK α2-/-, n=22).
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Figure 19. Histograms showing baseline ventilatory responses in wildtype and
Global AMPK α1 Knockout Mice. A.(i.) Resting respiratory rate (F), (ii.) Tidal volume
(VT) and (iii.) Significant decrease in resting minute ventilation (VE) in AMPK α1 KO
mice compared to WT (p<0.0005) (WT, n=21; AMPK α1-/-, n=33).
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Student’s t-Test, p<0.005) when compared to the WT mice (2.25±0.12 ml/min/g) (Figure
19, iii). When the WT and global AMPK α1 were exposed to 8% O2 the percent change
in frequency of the AMPK α1-/- mice (5.34±1.06%; unpaired Student’s t-Test, p<0.004)
was significantly less compared to the WT mice (13.89±3.04%) (Figure 20, i). The
percent change in tidal volume of the α1 KO (10.01±2.38%) mice was elevated
compared to the WT (4.79±2.64%) mice but was not significant (Figure 20, ii). Finally,
the percent change in minute ventilation at 8% O2 in the WT (19.04±4.12%) mice was
slightly elevated when compared to the knockout mice (15.73±2.54%) but was not
significantly different (Figure 20, iii).
The AMPK α2 KO mice were also used in plethysmography experiments to
determine their acute hypoxic ventilatory response.

Figure 21 shows the baseline

breathing rates at rest of the WT (n=21) and global AMPK α2 knockout mice (n=18).
The respiration rate or frequency of the WT (249.22±8.06 breath/min) mice was slightly
lower versus the AMPK α2-/- mice at rest (308.84±9.74 breaths/min) but it was not
significantly different (Figure 21, i). When comparing the tidal volume of the knockouts
to the WT (9.1±0.52 µl/g) mice, the AMPK α2-/- (5.3±0.39 µl/g; unpaired Student’s t
Test, p<0.00001) mice had a significantly attenuated tidal volume vs. the WT (Figure 21,
ii). In addition, there was a significant decrease in minute ventilation in the global
AMPK α2 KO (1.62±0.09 ml/min/g; unpaired Student’s t test, p<0.0005) mice compared
to the WT (2.25±0.12 ml/min/g) mice at rest (Figure 21, iii).
When the WT and AMPK α2 KO mice were exposed to 8% oxygen, there was a
significant decrease in the percent change in respiration rate between the AMPK α2-/-
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Figure 20. Percent change in ventilatory parameters in response to 8% hypoxia. (i.)
Significant decrease in the percent change in respiratory rate in the AMPK α1-/- mice
compared to wildtype (p<0.004), (ii.) Percent change in tidal volume, (iii.) Percent
change in minute ventilation (WT, n=21; AMPK α1-/-, n=33).
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Figure 21. Histograms showing baseline ventilatory responses in wildtype and
Global AMPK α2 Knockout Mice. (i.) Resting Breathing, (ii.) Significant decrease in
tidal volume in AMPK α2-/- mice compared to wildtype (p<0.0001), (iii.) Significant
decrease in resting minute ventilation in AMPK α2 KO mice compared to WT
(p<0.0005) (WT, n=21; AMPKα2-/-, n=18).
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Figure 22. Percent change in ventilatory parameters in response to 8% hypoxia in
WT and global AMPK α2 KO mice. (i.) Significant decrease in the percent change in
respiration frequency in AMPK α2 KO mice compared to WT (p<0.04), (ii.) Percent
change in tidal volume, (iii.) Significant attenuation (~80%) in % change in minute
ventilation in AMPK α2-/- mice when exposed to 8% O2 compared to WT (p<0.005)
(WT, n=21; AMPK α2-/-, n=18).
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(6.09±1.53%; p<0.04) and the WT (13.89±3.04%) mice (Figure 22, i). The percent
change in tidal volume observed in the AMPK α2-/- mice (-1.79±2.93%) decreased
compared to the WT (4.79±2.64%) mice but was not significant (Figure 22, ii). Finally,
upon exposure to 8% O2 there was a significant attenuation of % change in minute
ventilation in the global AMPK α2 KO (3.80±2.62%; unpaired Student’s t-Test, p<0.005)
mice by about 80% when compared to the WT (19.03±4.12%) mice (Figure 22, iii).
It is possible that knocking out AMPK globally may have an inhibitory effect on
the HVR through a mechanism mediated by something other than the carotid body. In
order to try and minimize possible central effects to knocking out AMPK globally, mice
that potentially had knockout of AMPK in tissues containing tyrosinse hydroxylase,
which includes the carotid bodies were used. The AMPK α2 subunits in the carotid
bodies of these targeted knockout mice should be deleted, thus sparing much of the
central processing hypoxic peripheral input (Gozal et.al., 2000; Takakura et.al., 2006).
The ventilatory response of WT (n=21), Floxed controls (FlFl/Fl; n=20), and AMPK α2
TH-targeted KO mice (THCre+/+FlFl/Fl; n=13) were examined to determine if a central
effect of global AMPK α2 knockout was removed.
Figure 23 illustrates the baseline breathing rates for the WT, floxed controls and
TH-targeted KO mice. There was no difference in the respiration rate between WT
(249.22±8.29) mice compared to the flox control mice (259.7±7.30) at rest; however, the
targeted KO (303.92±6.19) mice showed a significant increase in respiration rate
compared to wildtype mice (249.22±8.29; unpaired Student’s t-Test, p<0.00004) at rest
(Figure 23, i). When comparing the tidal volume at rest of the WT, flox controls, and
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Figure 23.

Histograms showing baseline ventilatory responses for wildtype, Flox

control (FlFl/Fl) and TH-Targeted knockout mice (ThCre+/+FlFl/Fl). (i.) Significant
increase in resting breathing in TH-targeted KO mice compared to WT (p<0.0004), (ii.)
Significant decrease in tidal volume in flox control mice and TH-targeted KO mice
compared to WT mice (FloxFl/Fl, p<0.0068; TH-targeted, p<0.008), (iii.) Significant
decrease in resting minute ventilation in flox control mice compared to WT (p<0.02)
(WT, n=21; FloxFl/Fl n=20; THCre+/+FlFl/Fl, n=13).
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targeted KO’s (Figure 23, ii), there was a significant decrease in the flox controls
(7.4±0.31 µl/g; unpaired Student’s t-Test, p<0.0068) compared to the WT mice (9.1±0.52
µl/g) as well as a significant attenuation in the tidal volume of the targeted KO
(6.98±0.48 µl/g; unpaired Student’s t-Test, p<0.008) when compared to wildtype mice at
rest.

The flox control mice also showed a significant decrease in resting minute

ventilation (1.90±0.068 ml/min/g; unpaired Student’s t-Test, p<0.02) when compared to
the WT mice (2.25±0.122 ml/min/g), but there was no significant difference between the
WT and ThCre+/+FlFl/Fl (2.12±0.153 ml/min/g) mice at rest (Figure 23, iii).
After exposure to 8% oxygen the flox controls (31.45±5.58%) showed no
significant difference in the percent change in respiration rate compared to the wildtype
mice (23.73±7.30%). There was a significant attenuation in the percent change in
respiration rate in the TH-targeted KO (-2.81±12.23; unpaired Student’s t-Test, p<0.007)
mice vs. the WT (31.45±5.58%) (Figure 24, i). Both the flox control mice (0.98±0.21%)
and targeted KO (1.03±0.31%) mice showed a slightly elevated percent change in tidal
volume when compared to the wildtype (0.33±0.22%) but neither were significantly
different (Figure 24, ii). In addition, there was no significant difference in the percent
change in minute ventilation between the flox controls (0.446±0.079%), ThCre+/+FlFl/Fl
(0.250±0.051%) and the wildtype (0.367±0.053%) mice (Figure 24, iii) when exposed
to 8% oxygen.
Thus, during exposure to 12% O2 AMPKα1 and AMPK α2 mice did not show a
significant difference in their hypoxic ventilatory response when compared to the
wildtype mice. As a result the level of hypoxia was decreased to 8%. Baseline minute
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Figure 24. Percent change in ventilatory parameters in response to 8% hypoxia in
WT, TH-targeted KO (ThCre+/+FlFl/Fl) and Flox control (FlFl/Fl) mice. (i.) Significant
decrease in the percent change in respiration frequency in TH-targeted KO mice
(p<0.007), (ii.)

Percent change in tidal volume, (iii.)

Percent change in minute

ventilation (VE) in flox controls and TH-targeted KO mice when exposed to 8% O2
compared to WT (WT, n=21; FloxFl/Fl n=20; THCre+/+FlFl/Fl, n=13).
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ventilation rates for both AMPKα1 and AMPK α2 mice were significantly less compared
to their wildtype counterparts. During exposure to 8% oxygen AMPKα1 and AMPK α2
KO mice showed a significant attenuation in the percent change in frequency, as well as
α2 KO mice having a significant decrease in the percent change in minute ventilation
(~80% less).

Ventilatory Response of Global AMPK α1 and AMPK α2 Knockout and THtargeted Knockout Mice to Hypercapnia
It has been shown that increasing inspired CO2 is a well established respiratory
stimulus (Haldane & Priestly, 1905) mediated in part, by the carotid body (Gonzalez,
et.al., 1994). It is believed that TASK channels play a role in the CO2-sensing ability
within the type I cells of the carotid body. Therefore the ventilatory response of the mice
to hypercapnia was done as control experiments to illustrate that AMPK plays no role in
how the type I cells of the carotid body sense changes in carbon dioxide. Figure 25
illustrates the ventilatory response of the WT (n=15), global AMPK α1 (n=29), and
AMPK α2 (n=22) knockout mice at resting breathing (0% CO2). The AMPKα1 KO
(222.23±11.00 breaths/min) mice have a slightly attenuated resting respiration rate
compared to the WT (254.75±12.59 breaths/min) but was not significant, whereas the
AMPK α2 KO mice have a significantly elevated resting respiration rate (291.1±11.94
breaths/min; unpaired Student’s t-Test, p<0.048) (Figure 25, i). There was no difference
in tidal volume between the AMPK α1-/- (5.96±0.23 µl/g) mice compared to the wildtype
(6.32±0.28 µl/g) at rest but the AMPK α2-/- mice (4.4±0.25 µl/g; unpaired
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Figure 25. Histograms showing hypercapnic ventilatory responses in wildtype,
AMPK α1 KO and AMPK α2 KO mice. A. (i.) Significant increase in resting
frequency in AMPK α2 KO mice compared to WT (p<0.048). (ii.) Significant decrease
in tidal volume in AMPK α2 KO mice compared to WT at rest (p<0.00013). (iii.)
Significant decrease in resting minute ventilation in AMPK α1 KO mice and AMPK α2
KO mice compared to WT at rest (α1-/-, p<0.004; α2-/-, p<0.01; WT, n=15; AMPK α1-/-,
n=29; AMPK α2-/-, n=22).
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Student’s t-Test, p<0.0001) had a significant decrease compared to the WT mice (Figure
25, ii). Both the global AMPK α1 KO (1.30±0.054; unpaired Student’s t-Test, p<0.004)
mice and AMPK α2 KO (1.28±0.079; unpaired Student’s t-Test, p<0.010) mice had a
significant decrease in minute ventilation at rest compared to the WT (1.60±0.09
ml/min/g) (Figure 25, iii).

Upon exposure to 7% CO2 the WT (20.06±6.13%) and

AMPK α1-/- (17.98±3.47%) mice did not show any significant difference in percent
change in respiration rate (Figure 26, i). The AMPK α2-/- (8.91±1.88%) mice showed a
decrease in the percent change in respiration rate during 7% CO2 but it was not
significant (Figure 26, i). The percent change in tidal volume was not significantly
different between the WT (10.36±3.31%), α1-/- (8.41±2.44%) or α2-/- (9.06±2.01%) mice
during 7% CO2 (Figure 26, ii). Both the AMPK α1 KO (26.82±3.29%) mice and AMPK
α2 KO mice (18.42±2.38%) showed a slight decrease in percent change in minute
ventilation (Figure 26, iii) compared to the WT mice (32.10±7.59%) when exposed to
7% CO2 but it was not significant.
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Figure 26. Percent change in ventilatory response when exposed to 7% CO2 in WT,
AMPK α1 and AMPK α2 KO mice. (i.) Percent change in frequency, (ii). Percent
change in tidal volume, (iii). Percent change in minute ventilation in AMPK α1 KO and
AMPK α2 KO mice compared to WT during 7% CO2 (WT, n=15; α1-/-, n=29; α2-/-,
n=22).
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Metabolic rates for Wildtype, Global AMPK α1 KO and Global AMPK α2 KO
Mice During Steady State.
Minute ventilation rates at rest in both global AMPK α1 and AMPK α2 knockout
mice were significantly attenuated as a result, metabolic experiments were run in order to
rule out a metabolic difference between the knockout and WT mice. Rates for mean
.
.
oxygen consumption (V O2), carbon dioxide excretion (V CO2) and respiratory exchange
ratio (R) for wildtype, AMPK α1 KO and AMPK α2 KO mice are shown in Table 2.
There were no significant differences between oxygen consumption in the wildtype
(82.34±6.62), AMPK α1 KO (80.70±7.28) and AMPK α2 KO (98.48±2.58) mice
(Figure 27, A). AMPK α1 KO (62.87±2.60) and AMPK α2 KO (65.46±2.12) mice
.
showed slightly elevated levels of V CO2 compared to wildtype (61.73±3.14) but were not
significant (Figure 27, B). The respiratory exchange ratio, which is the ratio of carbon
dioxide produced/oxygen consumed, showed no significant difference between the
wildtype (0.79±0.03), AMPK α1 (0.81±0.05) and AMPK α2 KO (0.66±0.02) mice
(Figure 27, C).
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.
Table 2. Mean V O2, V CO2 and Respiratory ratios (± standard error) for wildtype, AMPK
α1 KO and AMPK α2 KO mice used in metabolism trials (WT, n=11; AMPK α1-/-=7;
AMPK α2-/-=8).

Mouse ID

.
VO2 (ml/min/Kg)

.
VCO2 (ml/min/Kg)

Wildtype

82.34±6.62

61.73±3.14

Respiratory
Exchange Ratio
0.79±0.03

AMPK α1 KO

80.70±7.28

62.87±2.60

0.81±0.05

AMPK α2 KO

98.48±2.58

65.46±2.12

0.66±0.02
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Figure 27. Metabolism Histograms showing metabolic rate in wildtype, AMPK α1-/and AMPK α2-/- mice. A. No significant differences between mice in the rate of oxygen
.
uptake (VO2). B. No significant difference between mice in the amount of CO2 produced
.
(V CO2). C. No significant difference in mice in the ratio of carbon dioxide produced in
the tissue to oxygen consumed (R). (WT, n=11; AMPK α1-/-, n=7; AMPK α2-/-, n=8).
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Problems with the Targeted Knockout Mouse
To ensure that AMPK α2 knockout was targeted to TH-expressing tissue the
adrenal medulla and cortex were removed from TH-targeted mice and examined for the
presence of an AMPK signal. The adrenal medulla expresses tyrosine hydroxylase and
therefore the AMPK signal in this tissue should be absent or knocked out in a THtargeted KO mouse as Cre recombinase will be active. By contrast, the adrenal cortex
tissue does not contain tyrosine hydroxylase and should give a +/+ AMPK signal in a
targeted KO mouse. Figure 28 is a PCR gel showing the presence or absence of the
AMPK signal in the medulla and cortex for a WT mouse, an AMPK alpha 2 global KO
mouse and a TH-targeted KO mouse. The WT mouse shows a +/+ signal for AMPK in
both the medulla and cortex, which is what one would expect. When examining the
AMPK α2 global KO mouse, AMPK is not present in either the adrenal medulla or
adrenal cortex and this is also to be expected since AMPK is globally knocked out
throughout the entire mouse. In the targeted KO mouse there is a -/- signal in the medulla
for AMPK (top band), which is to be expected because the medulla is TH-positive tissue.
The bottom +/+ band in the medulla is a residual flox band because there are both TH
positive and TH negative tissue in the medulla. For example, chromaffin cells are TH
positive whereas blood vessels are TH negative. However, when looking at the THnegative cortex the top band is also showing a -/- signal for AMPK (Figure 28, red
circle), this should NOT occur because the cortex does not contain TH-positive tissue.
To ensure the reason for observing AMPK knockout in the adrenal cortex was not
due to contamination with medulla fragments, adrenal cortex tissue was taken from
outside the adrenal gland, which does not contact the medulla. The same results were
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Figure 28.

PCR of Targeted Knockout Adrenal Medulla (M) and Cortex (C)

Looking for Presence of AMPK α2 Signal. The wildtype mouse (WT) shows the
presence of AMPK (+/+) in both medulla (M) and cortex (C). The global KO mouse
(α2ko) has AMPK α2 (-/-) knocked out in both medulla and cortex because it is a global
KO vs. a targeted KO. The targeted KO mouse (target ko) shows knockout of AMPK α2
(-/-) in the medulla (top band) and the bottom band is a residual flox signal from non-TH
tissue. The targeted KO mouse also shows knockout of AMPK α2 (-/-) in the cortex.
Red circle indicates lack of AMPK in cortex, which should not occur because the cortex
does not contain tyrosine hydroxylase and should not be cut out in the targeted KO
mouse.
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found each time: TH-negative cortex showed AMPK α2 knockout. This lack of AMPK
signal in the cortex was the first indication there was a potential targeting problem with
the targeted KO mice.
It was discovered that two main problems presented themselves with regard to the
targeted KO mice (Figure 29). The first issue was a loss of the flox signal in the
targeted KO mice. Primers designed to identify whether a mouse was +/+, -/+ or -/- for
floxed AMPKα2 failed to produce an identifiable band. Figure 29 (issue 1) shows a
single targeted knockout mouse that is +/+ for Cre but does not have a Flox signal. The
lack of a flox signal could possibly be explained if somehow the animal had lost all
AMPK α2. Indeed the AMPK α2 signal from the tail was -/- in this mouse. The fact that
the AMPK signal is -/- and the flox signal is absent would indicate this mouse was a
global knockout instead of a TH-targeted mouse. If this mouse was a true targeted KO
mouse, AMPK would still be present because the tissue for the PCR was taken from the
tail where no TH-positive tissue should be found.
There was also a second issue that arose with the targeted knockout mice. The
ideal targeted knockout mouse is +/+ for Cre and +/+ for Flox, which appears to be the
case for the single targeted KO mouse shown in Figure 29 (issue 2). However, when
looking for the AMPK signal in this mouse it was absent which should not be the case
because tail tissue does not contain tyrosine hydroxylase. Knockout of AMPK in the tail
tissue should only occur if Cre was sending the knockout throughout the entire mouse
versus just TH-positive tissue. It is possible that Cre is not targeting to
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Figure 29. PCR gel illustrating the two main issues in regards to the TH-targeted
knockout mice. Issue 1: Loss of flox signal in the targeted knockout mouse. DNA from
tail tissue shows the mouse is +/+ for Cre but the flox signal is absent and the mouse is -/for AMPK α2. Red circles indicate loss of flox signal and -/- band for AMPK α2. Issue
2: Gel seems to illustrate the preferred targeted knockout mouse genotype (+/+ for Cre,
+/+ for Flox), but shows a negative signal for AMPK, which should not occur because
the DNA is from tail tissue. Red circle indicates negative signal for AMPK α2.
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Figure 29.
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just TH-positive tissues but to other tissue as well. AMPK should only be knocked out in
TH-positive tissue if the cre is correctly targeted/expressed.
As a result of the two aforementioned genotyping issues (spontaneous global KO
and mis-targeting of cre) the parents of the targeted knockout mice were examined to
determine if the parent’s genotype could explain the unexpected results that were
obtained. Figure 30 examines the presence or absence of Cre, Flox and AMPK in the
father (F), mother (M) and offspring (O) of a single targeted knockout mouse. The father
and mother were +/- for Cre and produced a +/+ Cre offspring. The parents were +/- for
Flox but the flox signal was lost in the offspring, which prompted further examination of
the father, mother and offspring for the presence of AMPK. Both parents were +/+ for
AMPK and the offspring was -/- for AMPK α2, which is not genetically possible since
both parents were +/+ for AMPK α2. It appears as if the offspring was a global knockout
mouse instead of a targeted KO mouse. Mice that showed a loss of the flox signal were
not used for any experiments, so no plethysmography or imaging data were collected
from these mice.
Next, the parents of a mouse that appeared to be an ideal targeted AMPK KO
were examined for the presence of Cre, Flox and AMPK. Upon examination of the PCR
gel shown in Figure 31 both the father and mother were +/- for Cre and Flox which gave
an offspring that was +/+ for Cre and +/+ for Flox. The offspring of this cross appeared
to be an ideal targeted KO (ThCre+/+FloxFl/Fl) and the mice were used in plethysmography
experiments. However, when the presence of AMPK α2 was looked for, the offspring
showed a negative signal while the parents were +/+ for AMPK α2. If
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Figure 30. PCR gel showing the presence or absence of Cre (C), Flox (F) and AMPK
α2 (A) in the Father (F), Mother (M) and Offspring (O) of a single TH-targeted
knockout mouse in regards to Issue 1. Both father and mother are +/- for Cre and flox
giving an offspring that is Cre+/+ but lacks a flox signal. Both parents are +/+ for AMPK
but the offspring shows a -/- signal for AMPK indicating the offspring is a global
knockout. The first red circle indicates a lack of flox signal in the offspring while the
second circle indicates a lack of a negative signal in the parents for AMPK, making it
difficult to explain the -/- AMPK in the offspring.
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Figure 31. PCR gel showing the presence or absence of Cre (C), Flox (F) and AMPK
α2 (A) in the Father (F), Mother (M) and Offspring (O) of a single TH-targeted
knockout mouse in regards to Issue 2: Both father and mother are +/- for Cre and flox
giving an offspring that is Cre+/+Flox+/+, which is the ideal genotype for the targeted KO.
Both parents are +/+ for AMPK α2 but the offspring shows a negative signal for AMPK,
which if the offspring were a true targeted KO AMPK α2 should be present because tail
tissue does not contain TH.
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this mouse was truly a targeted KO mouse an AMPK α2 signal should be seen because
the tissue used for the PCR came from the tail. The tail does not contain tyrosine
hydroxylase and thus the AMPK signal should be present whether the animal is a targeted
knockout or a wild type.
It seems as if Cre was targeting not only to TH-tissue but was cutting out AMPK
in other tissues as well. The presence of AMPK in these animals was not examined
before using them for plethysmography experiments since they were +/+ for Cre
and +/+ for flox, which lead me to believe they were indeed a targeted knockout. As
a result of the genotyping issues that have come about, plethysmography data collected
from the targeted animals is not reliable because it is not known if AMPK α2 was
knocked out in tissues other than TH-containing tissue.
To reiterate, to check that the targeted mice were indeed targeting knockout
properly, the adrenal medulla and adrenal cortex were screened for the presence
of an AMPKα2 signal. Knockout of AMPK α2 was shown in the medulla, which is to be
expected due to the presence of tyrosine hydroxylase. However, knockout was also seen
in the cortex, which is an issue because the cortex does not contain TH-positive tissue.
Another issue was the loss of the flox signal in the targeted knockout giving offspring
that appeared to be global knockouts, which cannot be explained and thus these mice
were not used in plethysmography or calcium imaging.
The final targeting issue came about when it appeared the perfect targeted
knockout mouse had been generated because it was +/+ for Cre and +/+ for flox but
showed knockout of AMPK α2 in tail tissue. Again, data from these mice were not
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useable due to the uncertainty of whether or not AMPK α2 knockout had been targeted
appropriately.

Calcium Imaging
Type I Cells Response to Hypoxia from Global AMPK α1 and AMPK α2 Knockout
Mice
Functional carotid body type I cells are known to depolarize in response to
hypercapnia or hypoxia leading to voltage-gated calcium entry (Buckler & VaughanJones, 1993, 1994a,b) and neurotransmitter release. Isolated type I cells from wildtype
and AMPKα1 KO mice were subject to hypercapnic (20% CO2) and hypoxic (~10 torr)
solutions and levels of intracellular calcium were measured. The AMPK α1 KO type I
cells had a strong hypercapnic response but a mixed response to hypoxia. Figure
32(A.) illustrates a hypoxic response in an AMPK α1 KO type I cell whereas Figure
32(B.) shows a type I cell from an AMPK α1 KO mouse with little to no response to
hypoxia.
Calcium imaging results from AMPK α2 KO mice type I cells show they respond
nicely to hypercapnia (20% CO2) but do not show a hypoxic (~10 torr) response as seen
in the wildtype cells. Wildtype mice type I cells (Figure 33A) respond robustly to HC as
well as hypoxia. The AMPK α2 KO type I cells have a slightly attenuated hypercapnic
response about 28% less versus the wildtype cells (Figure 33B) and also show a
significant decrease in hypoxic response. The lack of hypoxic response in the AMPK α2
KO type I cells is illustrated by a significantly reduced [Ca2+]i ratio (p<0.003) compared
to the wildtype cells (Figure 33C).
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Figure 32. Ca2+ Imaging Results from Global AMPKα1 Knockout Mice (A.) A
global AMPK α1 KO mouse type I cell response to hypercapnia (HC) and hypoxia. (B).
Type I cell from a global AMPK α1-/- mouse response to (HC) but little to no response to
a hypoxic stimulus (WT, n=6; AMPK α1-/-, n=2).
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Figure 33. Ca2+ Imaging Results from Global AMPK α2 Knockout mice (A.)
Wildtype mice type I cells respond to hypercapnia (HC) and hypoxia. (B). Global
AMPK α2-/- mice respond to (HC) but have impaired ability to transduce a hypoxic
stimulus compared to WT mice. (C.) Significant decrease in cells response to hypoxia in
AMPK α2-/- mice compared to WT mice (p<0.003) (WT, n=6; AMPK α2-/-, n=5).
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DISCUSSION

AMPK and Pharmacological Tools
Previous work attempting to establish the role of AMPK has been largely
pharmacological and many of these agents have proven to have some non-specific or offtarget effects independent of AMPK, which suggests caution must be used if utilizing
these compounds to examine the role of AMPK in hypoxic chemotransduction. For
example, Emerling, et.al. (2007) have shown that Compound C, a known inhibitor of
AMPK, was able to suppress the hypoxic activation of HIF-1 in cells lacking AMPK α1
or AMPK α2. These data also show Compound C inhibits respiration independent of
AMPK illustrating an off-target effect. Furthermore, Compound C is known to be a
more potent inhibitor of TWELVE other kinases besides AMPK (Bain et.al., 2007).
Caution should also be used when interpreting data collected using the AMPK
agonist, AICAR as Guigas et.al. (2007) showed cellular respiration was inhibited in rat
hepatocytes that lacked either AMPK α1 or AMPK α2 subunits when AICAR was used.
The inhibition of respiration in these knockout mice by AICAR was mediated
independent of AMPK α subunits. To get around the possible uncertainties observed
with pharmacological tools, global knockout mice were utilized in this dissertation to
characterize the role of specific AMPK α subunits to provide further concrete evidence
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for AMPK’s role in the transduction of hypoxic signaling by the carotid body and the
acute hypoxic ventilatory response.

Global Knockout Mice and Hypoxic Response to Plethysmography
Global knockout mice have been the foundation for research in this project. The
ideal knockout mouse for these experiments would have been to knockout both AMPK
α1 and AMPK α2 subunits in the same animal but this is embryonically lethal (Viollet et.
al., 2003b) and thus not feasible. A double knockout would have guaranteed that AMPK
had no catalytic activity and would have allowed for examination of the role each alpha
subunit may play. The double knockout model would have avoided the possibility that
knocking out one of the subunits (i.e. α1) would result in compensation by the other (α2)
and vice versa. A double KO mouse is not possible thus; mice used in the experiments
had either the AMPK α1 or AMPK α2 subunit knocked out globally. The global
knockout mice allowed for examination of the role the AMPK alpha subunit(s) played in
response to a hypoxic challenge.
Upon exposure to acute hypoxia the carotid bodies become stimulated resulting in
an increase in minute ventilation which peaks in the first few minutes (Powell et. al.,
1998; Smith et.al., 2001). Minute ventilation then declines to a point that is still higher
than at normoxia depending on the level of hypoxia. This decrease in minute ventilation
is termed hypoxic ventilatory decline (HVD) (Figure 34). Hypoxic ventilatory decline
generally occurs after a prolonged exposure to hypoxia (5-30 minutes) (Powell et.al.,
1998). In order to avoid HVD in the plethysmography experiments conducted in this
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Figure 34. Hypoxic Ventilatory Decline (HVD). Time course of ventilatory response
to hypoxia. Peak aHVR is the peak acute hypoxic ventilatory response, HVD is the
hypoxic ventilatory decline.
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dissertation, all hypoxic challenges were limited to 3 minutes and plethysmography data
were taken from the peak hypoxic response. All wildtype and global AMPK α1 and
AMPK α2 knockout mice were first exposed to 12% oxygen to examine the role AMPK
played in the hypoxic response (Figure 18). At 12% oxygen the global AMPK α2 KO
mice showed a decrease in percent change in respiration rate as well as minute ventilation
and the AMPK α1 KO mice showed a decrease in percent change in tidal volume and
minute ventilation but none of these were significantly different from the WT responses.
It appeared that 12% oxygen was not a sufficient stimulus to produce a significant
hypoxic response between knockout and wildtype mice, thus the hypoxic challenge was
switched to a more robust hypoxic challenge of 8% oxygen.
At rest, the AMPK α1 KO mice showed no difference in frequency or tidal
volume when compared to wildtype (Figure 19), however, the AMPK α1 KO mice did
show a significant attenuation (p<0.0005) in minute ventilation compared to WT mice.
Upon exposure to 8% oxygen (Figure 20) the AMPK α1 KO mice had a significant
decrease in the percent change in frequency of breathing (P<0.004). However, there was
no significant difference in the percent change in tidal volume and no significant
difference in percent change in minute ventilation in the AMPK α1 knockout when
compared to WT. Even though there is no significant difference between the KO and WT
with regard to % change in minute ventilation, it does appear that knocking out the
AMPK α1 subunit may have some affect on the response to hypoxia, as there is a
significant decrease in the frequency response of the KO mice to hypoxia.
In the AMPK α2 KO mice there was a slight increase in frequency of breathing at
rest but it was not significant when compared with wildtype mice. In addition these KO
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mice showed a significant decrease in tidal volume (p<0.00001) and minute ventilation
(p<0.0005) at rest (Figure 21) compared to the wildtype mice. When the AMPK α2 KO
animals were exposed to 8% oxygen there was a significant decrease in the percent
change in frequency (p<0.04) as well as a significant attenuation in the percent change in
minute ventilation (p<0.005). The % change in minute ventilation was about 80% less
when compared to the WT mice at 8% oxygen (Figure 22), which demonstrates that
knocking out AMPK α2 subunits affects the acute hypoxic respiratory response of mice.
These data also lend further support that AMPK plays a role in the acute HVR.
The plethysmography data from the global knockout mice show a significant
decrease in percent change in frequency of breathing during exposure to 8% oxygen in
both the global AMPK α1 and AMPK α2 knockout mice, however there was no
significant percent change in tidal volume. This observation warrants further discussion.
There was also a significant decrease in the percent change in minute ventilation in the
AMPK α2 KO mice. It has been reported in animals where carotid body resection has
occurred the entire hypoxic ventilatory response is gone however, if there is tonic sinus
afferent discharge from the carotid body a partial ventilatory response to hypoxia can
take place (Smith et.al., 2010; Hill et.al., 2011). This partial ventilatory response is
possible due to specialized neurons, which function as central oxygen-sensors and are
found in the Pre-Bötzinger complex of the respiratory network of the brain stem (Hill
et.al., 2011). As long as the carotid sinus nerve offers some afferent discharge, the PreBötzinger is able to compensate for the loss of oxygen-sensing by the carotid bodies
(Bissonnette, 2000; Hill et.al., 2011; Smith et.al., 2010; Curran et.al., 2000). Thus in
terms of a hypoxic response, the carotid body is necessary for an increase in breathing
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frequency but not tidal volume (Bissonnette, 2000; Hill et.al., 2011). It appears as if the
frequency response to hypoxia is under the control of the peripheral chemoreceptors
whereas response to tidal volume can be mediated by central chemoreception, which
could help explain the lack of significant tidal volume response reported in the
aforementioned data.
However, a potential methodological issue must also be discussed. The range of
tidal volume values reported in this dissertation is quite variable and a few appear to be
less than tidal volume values reported in the literature (Trapp et.al., 2008). Another
possible explanation for the range of tidal volume values collected is the
plethysmography equipment set up. If the head of the mouse was not properly held in
place by the inflatable cuff air could possibly have leaked out at this point. Thus tidal
volume values would be reduced but frequency readings would remain accurate. In order
to address the potential issue with the tidal volume values in regards to equipment set up,
use of an unrestrained whole body plethysmography unit might prove beneficial.
Unrestrained whole body units would get rid of the animal head/body restraint issue and
there is plenty of data in the literature to compare values. The only downfall to the
unrestrained whole body unit is that it costs around $50-60,000, which at the time was
not a feasible purchase.

TH-targeted Knockout Mice and Hypoxic Response to 8% Oxygen
In addition to the global knockout mice, mice were also used which targeted
knockout of the AMPK α2 subunit to tyrosine hydroxylase containing tissue that
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included the carotid body. Targeted knockout mice were used to try and minimize
possible central effects of knocking out AMPK by focusing on targeting AMPK α2
knockout to neurons containing TH. The targeted knockout would also minimize
peripheral effects that may have occurred in the global AMPK KO mice.
Knocking out AMPK subunits in the brain may affect the communication line
between the carotid body and the central mechanisms of ventilatory control. Therefore,
AMPK α2 subunits were deleted in TH-positive cells, which includes carotid body type I
cells but was spared in much of the brain regions that process the hypoxic peripheral
input (Gozal et.al., 2000; Takakura et.al., 2006). It has been postulated that potential
sites for convergence between the carotid body and the brain stem include the nucleus
tractus solitarii (NTS) and retrotrapezoid nucleus (RTN) (Blain et.al., 2010). RTN
neurons receive excitatory input from afferents of the carotid chemoreceptors which
bypass the respiratory network and are believed to involve a glutamatergic neuron found
in the NTS (Takakura et.al., 2006). Neurons of the commissural NTS (commNTS) are
activated by carotid body activity and innervate the RTN via projections that are mainly
glutamatergic. Because these neurons are glutamatergic in nature and not tyrosine
hydroxylase positive, these areas of the brain should not be affected in the targeted KO
mice.
Some of the central TH neurons however can affect the chemoreflex of the carotid
body (Zhang & Mifflin, 2007; Viemari, 2008). Certain central noradrenergic neural
structures of the brain such as A1, A2, A5 and A6 cell groups, are activated upon
stimulation of the peripheral chemoreceptors. These structures innervate and possibly
modulate neurons found in the caudal nucleus tractus solitarius (cNTS), which is the
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location of the first central projections from the carotid bodies (Zhang & Mifflin, 2007).
A2 neurons specifically receive sensory input from the peripheral chemoreceptors, which
suggests they play a role in modulating the respiratory chemo-reflex (Viemari, 2008). It
is also believed that A6 neurons are among the earliest born neurons (Lauder & Bloom,
1974) and therefore may have some role in the maturation of neural processes including
that of the respiratory network (Viemari, 2008).
Since these norepinephrine neurons express tyrosine hydroxylase and possibly
affect the carotid body chemoreflex (Zhang & Mifflin, 2007; Viemari, 2008), data from
the TH-targeted knockout mice must be interpreted with caution. Knock out of AMPK
α2 subunits in these TH-positive neurons may affect the signal sent from the brain to the
respiratory network once the carotid bodies are stimulated.
Data were collected from the TH-targeted KO mice in order to examine their
hypoxic ventilatory response (Figure 24). When exposed to 8% oxygen, the TH-targeted
KO mice (ThCre+/+FlFl/Fl) had a significantly attenuated percent change in frequency
(p<0.03) compared to the WT and flox control mice. However, there was no significant
difference between the percent change in tidal volume and percent change in minute
ventilation among the groups. There were some concerns raised with these data since the
global AMPK α2 KO mice showed a significant attenuation in minute ventilation during
hypoxia but the targeted knockout minute ventilation values were not significant. A
possible explanation is the TH-targeting may have not worked properly. As mentioned
earlier, issues arose in regards to the targeting of AMPK α2 KO in TH-containing tissues
as to the actual location of the knockout. The mice appeared to be the perfect targeted
knockout because they were +/+ for Cre and +/+ for flox but lacked the presence of
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AMPK α2 in tail tissue (Figure 29, issue 2). The lack of AMPK α2 in the tail is
problematic because the tail does not contain TH-positive cells, thus AMPK should not
be knocked out. Knockout of AMPK in the tail would occur only if Cre was somehow
sending the knockout throughout the entire mouse versus just the TH-positive cells.
Lindberg et.al., (2004) were able to demonstrate that cre-mediated site- specific
recombination was successful by using a marker gene along with the loxP sites to detect
recombination. These data illustrate that cre recombinase does in fact work therefore
something in our mouse cre recombinase system is not working properly. Thus,
plethysmography data collected from the TH-targeted KO mice cannot be reliably
interpreted, as it is now evident that these animals were not properly targeted knockout
mice.

Global AMPK Knockout Mice Hypoxic Response and Calcium-Imaging
To provide further support to the attenuated response to hypoxia observed during
plethysmography experiments in the AMPK global knockout mice, FURA-2 calcium
imaging techniques (Wyatt & Buckler, 2004; Wyatt et.al., 2007; Burlon et.al., 2009)
were used to assess the functional integrity of the isolated carotid body type I cells.
Isolated type I cells from WT mice were shown to depolarize in response to hypercapnia
and/or hypoxia which led to entry of voltage-gated calcium (Buckler & Vaughan-Jones,
1993, 1994a,b) and neurotransmitter release.
Type I cells from the global AMPK α1 KO mice exhibited a robust response to
hypercapnia but showed a mixed response to hypoxia. Figure 32A, illustrates the
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hypoxic response of a type I cell from an AMPK α1 KO mouse. A strong response to
hypercapnia was observed in addition to a small hypoxic response, whereas in Figure
32B, another AMPK α1 KO type I cell also showed a response to hypercapnia but little
to no response to hypoxia. Thus, it appears as if there is a mixed hypoxic response from
the type I cells of the AMPK α1 KO mice. The variable Ca2+ imaging response from the
α1 KO mice seems to coincide with the variable response also seen in the
plethysmography data where the percent change in frequency response to hypoxia was
significantly less than the wildtype but, percent change in tidal volume increased and
percent change in minute ventilation to hypoxia decreased but not significantly. In order
to gain a better understanding of the aforementioned mixed hypoxic response, an increase
in cell numbers is required for the global AMPK α1 KO imaging experiments.
Calcium imaging data collected from type I cells of global AMPK α2 KO mice
showed a strong response to hypercapnia (Figure 33B). The hypoxic response was
significantly smaller in the AMPK α2 KO compared to the control type I cells. This
decrease in hypoxic response is illustrated in Figure 33C by the significantly (p<0.03)
lower ratiometric signal in the AMPK α2 KO type I cells compared to the WT cells. The
significant attenuation of the hypoxic response in the global AMPK α2 KO type I cells
confirms that the expression of the AMPK α2 subunit is necessary for a complete acute
HVR and a complete response of the carotid body type I cells to hypoxia. The lack of
response to a hypoxic stimulus in the global AMPK α2 KO mice carotid body type I cells
appears to support the reduced HVR observed in the AMPK α2 KO mice observed
during the plethysmography experiments. The data show not only a reduced hypoxic
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ventilatory response at the whole animal level but also a reduced response at the cellular
level.
The mixed response of the AMPK α1 KO mice shown in the Ca2+ imaging data
could be the result of AMPK α2 subunits compensating for the KO of α1 in some of the
type I cells. The expression level of each subunit varies among cells (Li et.al., 2006),
thus one subunit may be expressed in higher amounts versus the other allowing it to
compensate for knockout of the other subunit. The AMPK α1 subunits may not be able
to compensate for the loss of the AMPK α2 subunits, which may explain the lack of
hypoxic response in the AMPK α2 KO mice. Since the animals are global AMPK
knockout mice and AMPK is knocked out throughout the entire organism central effects
may be greater in the AMPK α2 KO versus the AMPK α1 KO mice due to tissue specific
subunit expression differences. Currently this is speculation and increasing (n) numbers
are required to help strengthen this argument. Further data collection will hopefully result
in a more consistent response to allow for a more solid explanation.
There appears to be almost a complete total ablation of the hypoxic response in
AMPK α2 KO mice but not in AMPK α1 KO mice. Both the AMPK α1 and AMPK α2
subunits appear to phosphorylate similar targets. It is therefore unlikely that AMPK α1
and AMPK α2 have different targets in the type I cells so this cannot explain the
observed differences with the knockout. However, the expression levels of each subunit
may vary in the carotid body therefore giving different results. Expression of one subunit
may be at a higher level and when it is knocked out this may have a larger effect on
signal transduction than knocking out a subunit with lower expression levels.
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Also, it is not known what the tissue specific subunit combinations are, so
different isoforms of AMPK maybe expressed at different levels in the different KO
mice. The various subunit combinations may target AMPK expression to different
locations such that the AMPK α2 subunits may be targeted to the plasma membrane
whereas the α1 is localized elsewhere. It has been reported in a variety of cell lines and
skeletal muscle tissue (Salt et.al.,1998; McGee et.al., 2003) that a significantly greater
portion of AMPK α2 is localized in the nucleus versus that of the α1 subunit. Therefore,
knocking out one or the other subunit may result in a different response based upon
subunit location and expression level. This may help to explain why there is complete
knockout of the hypoxic response in the AMPK α2 global KO mice but a mixed response
reported in the α1 KO mice. In order to quantify alpha subunit expression levels, a
Western Blot would be an ideal tool, however, due to the small size of the carotid body
very little tissue is available so a Western Blot would not be possible. The only
alternative possible method is to use single-cell RT-PCR to examine the protein level
expression of AMPK α1 and AMPK α2 subunits to determine if one subunit is being
expressed at a higher level.

AMPK and Multiple Targets
One challenge in carotid body research is the interspecies heterogeneity of
oxygen-sensitive ion channels. Many of the channels expressed in the carotid body are
not oxygen sensitive in other tissues. The absence of oxygen sensing capabilities is due
to a lack of the necessary pathway to sense changes in oxygen levels and inhibit the
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potassium channel. Recent research has shown that AMPK has multiple ion channel
targets (Dallas et.al., 2009; Evans et.al., 2009; Kréneisz et.al., 2009). Expression of
oxygen-sensitive potassium channels inhibited via activation of AMPK is species
dependent and expression of these channels is also different among animals. For example
it has been reported that mice have the following oxygen-sensitive K+ channels: Kv2.1
(Ikematsu et.al., 2011), Kv3 (Pérez-García et.al., 2004), and possibly TASK-1 (Trapp
et.al., 2008); whereas rats are shown to have BKCa (Peers, 1990; Wyatt & Peers, 1995),
TASK1/3 (Buckler, 1997; Buckler et.al., 2000; Kim et.al., 2009) and possibly TREK
(Kréneisz et.al., 2009) channels. AMPK activation leads to phosphorylation of a target
protein(s) and the aforementioned potassium channels have proteins that contain AMPK
phosphorylation sites, thus more than one potassium channel maybe inhibited when
AMPK is activated. As a result, it is possible to have multiple oxygen-sensitive channels
in an animal. Knocking out or altering one of the channels may still result in retention of
a hypoxic response because another AMPK targeted channel may be able to compensate
for the loss (Oretega-Sáenz, et.al., 2010). Thus, it appears there is evidence in favor of
AMPK being promiscuous because it is able to interact with multiple ion channel targets
in different species.

Hydrogen Sulfide
In addition to AMPK it has been suggested over the last year or two that hydrogen
sulfphide, a naturally occurring ‘gasotransmitter’, plays a role in carotid body oxygen
sensing through redox modulation in type I cells (Li et.al., 2010; Peng et.al., 2010).
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Hydrogen sulfide is produced endogenously in cells via the breakdown of cysteine and
homocysteine by the enzymes cystathionine-β-synthase (CBS) and cystathionine-γ-lyase
(CSE) (Mustafa et.al., 2009; Gadalla & Snyder, 2010). Cystathionine-β-synthase is the
main H2S producing enzyme found in the brain whereas, cystathionine-γ-lyase is found in
the glomus cells of the carotid body (Peng et.al., 2010; Li et.al., 2010 ). Hypoxia
increases the production of H2S in the carotid body (Peng et.al., 2010) via a stimulus
dependent manner. The mechanism as to how H2S actually stimulates the carotid body is
not exactly known but it has been shown that excitation of chemoreceptors through
exogenous H2S can be blocked by removing external calcium (Li et.al., 2010; Peng et.al.,
2010). Inhibition of BKCa channels (Li et.al., 2010) by H2S has been reported but this
alone is not likely to excite the type I cells because these potassium channels are not
active under resting conditions (Buckler, 1997).
H2S has been reported to excite carotid body type I cells through inhibition of a
background (TASK) potassium current leading to cell depolarization and voltage-gated
entry, which mirrors the response to hypoxia (Buckler, 2012). Concerns have arisen in
regards to the concentrations of exogenous H2S required to excite the chemoreceptors and
if these levels mirror those found in vivo (Haouzi et.al., 2011). Hydrogen sulfide is
highly membrane permeable and in order to generate a [Ca2+]i response levels of H2S
need to be greater than 2.5 µM and in some cases greater than 7.5 µM (Mathai et.al.,
2009). The extreme levels required to generate even a small response pose a problem for
H2S to be seen as an oxygen sensor because type I cells are not capable of producing H2S
at this level (Buckler, 2012).
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H2S is also a known cytochrome oxidase inhibitor (Erecinska & Wilson, 1981)
and has been shown to inhibit mitochondrial function via NADH autofluorescene at
concentrations of 2.5 µM (H2S) and above (Buckler, 2012). It does not appear as if H2S
plays any significant role outside of inhibition of oxidative phosphorylation, as it does not
have any further effect on channel activity in the presence of cyanide (Buckler, 2012). In
addition, the extreme levels of hydrogen sulfide required to excite carotid body type I
cells does not make H2S a likely candidate for mediating hypoxia in isolated type I cells
as they are not capable of generating such large amounts of H2S.
This dissertation suggests that AMPK does indeed couple hypoxic inhibition of
oxidative phosphorylation of type I cells and plays a key role in the acute hypoxic
ventilatory response. The data show that AMPK α subunits are necessary for a complete
hypoxic ventilatory response as well as carotid body type I cells response to hypoxia.
This work is supported by preliminary data from collaborators, in which knock out of
LKB1, an upstream kinase of AMPK (Figure 5), in type I cells also gives an attenuated
hypoxic ventilatory response in mice (Evans, 2012). Thus, not only does knockout of
AMPK α catalytic subunits affect the hypoxic response, but also knocking out an
upstream kinase which activates AMPK results in an attenuated HVR. These data
suggest that the LKB1-AMPK signaling pathway is required for a hypoxic response
coupled by the carotid body to regulate oxygen and energy supply at the whole body
level.
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Summary of Findings
•

During exposure to 8% oxygen, both AMPK α1 and AMPK α2 knockout mice
have a significant decrease in percent change in frequency of breathing

•

AMPK α2 knockout mice also show a significant attenuation in percent change in
minute ventilation during exposure to 8% oxygen

•

The plethysmography data show the AMPK α subunits maybe involved in
baseline breathing and generation of an acute hypoxic response

•

Calcium imaging data show a decrease in the hypoxic response may be due to an
effect at the level of the carotid body

•

Knocking out AMPK globally could have central effects, thus TH-targeted
knockout mice could be useful genetic tools to minimize possible central effects
of knocking out AMPK
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Future Studies

One methodological approach that might get around the problem of non-selective
targeting of AMPK knockout is to block or knockdown its expression through RNA
interference. RNA interference is a process where double stranded DNA (dsDNA) is
able to regulate gene expression. Small interfering RNA (siRNA) is a double stranded
RNA molecule that is 21 nucleotides in length and is complementary to an mRNA
transcript (Fire et.al., 1998). When siRNA is introduced into a cell one strand is
processed into the RNA-induced silencing complex (RISC) where it binds the
complementary mRNA (Hammond et.al., 2000). The nuclease activity of RISC results in
the complimentary mRNA being degraded by a member of the Argonaute (AGO) family
(Hammond et.al., 2001), which no longer allows for protein translation (Scherr et.al.,
2003; Doi et.al., 2003). SiRNA is not useful for long-term studies as it is diluted upon
cell division (Rao et.al., 2009).
An alternative method is to use short hairpin RNAs (shRNAs) to knockdown a
specific target protein. shRNA is a sequence of RNA containing a tight hairpin structure
which is used to silence gene expression through RNAi (Bernstein et.al., 2001). shRNA
is transcribed from a DNA template and uses a vector introduced into cells via the U6
promoter ensuring shRNA is always expressed (Harborth et.al., 2003; Elbashir et.al.,
2001). The vector allows for heritable gene silencing as it is passed onto daughter cells.
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Generation of a novel shRNA, which simultaneously targets both the AMPK α1 and
AMPK α2 subunits, has been developed in collaboration with Dr. Tom Brown’s lab,
Wright State University. Tissue-specific knockdown of AMPK α1 and AMPK α2 was
accomplished through an shRNA construct (Figure 35). The construct is under a U6
promoter that is disrupted by a loxP cassette. The loxP cassette contains a stop sequence
that is flanked on either side by a loxP site. When the promoter contains this cassette it
becomes non-functional and the shRNA is not expressed and knockdown of AMPK does
not occur. A tyrosine hydroxylase tissue specific promoter was used to direct the
expression of Cre recombinase with a Myc tag (pLv-MCS-THp-CreMyc). The use of
Cre, along with the shRNA that has a disrupted promoter will restore the promoter so
shRNA is made in only cells that express TH, which includes the carotid body. The final
construct has been generated and is currently being put into lentivirus. Lentivirus will
infect 2-8 cell mice/rat embryos to ensure a full body incorporation of lentiviral DNA.
All cells within the embryo will contain the viral DNA and only those cells expressing
TH will make the shRNA and have knockdown of AMPKα1 and AMPK α2. Once
infected the embryos will be transplanted into a pseudopregnant mother. Tissue specific
knockdown of both AMPKα1 and AMPK α2 should occur in the embryos only in TH
positive tissue and should not result in lethality since it is knockdown and not total
knockout of both AMPK subunits. These animals will then be used by the Wyatt lab to
examine the whole animal hypoxic response via plethysmography as well as look at the
carotid bodies to further examine the role AMPK has in oxygen sensing of the type I
cells.
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Figure 35. shRNA Construct. (A.) shRNA structure under control of a U6 promoter.
(B.) shRNA structure with disrupted U6 promoter. (C). DNA Recombination catalyzed
by cre recombinase at loxP sites located between U and Stop sequence and between the
Stop sequence and 6P. The Stop sequence is removed following binding of cre
recombinase at the loxP sites with construct illustrated in (B.). (D). Virus structure.
U6P: promoter; shRNA: short hairpin RNA; Stop: stop sequence; LoxP: loxP sites;
U/6P: disrupted promoter; ThP: tyrosine hydroxylase promoter; Cre: cre recombinase;
Myc tag: (pLv-MCS-THp-CreMyc) TH tissue specific promoter to direct expression of
cre recombinase with the Myc tag.
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Another alternative approach to targeting knockout of AMPK besides the THtargeted knockout mice would be to use dopamine transporter (DAT) (Augood et.al.,
1993) cre mice to specifically target knockout of AMPK to dopaminergic neurons in cre
recombinase expressing mice. In order to direct expression of cre recombinase to
dopaminergic neurons, cre is inserted downstream of the endogenous promoter DAT
(DAT-cre) (Zhuang, et.al., 2005). DAT-cre mice would also allow for AMPK α2
subunits to be deleted in the carotid body type I cells but again be spared in most of the
central processing of hypoxic peripheral input.
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Appendix
5-HT: 5-hydroxytryptamine
ACh: acetylcholine
ADP: adenosine diphosphate
AGO: Argonaute
AICAR: 5-aminoimidazole-4-carboxamide ribose α: alpha
AMP: adenosine monophosphate
AMPK: amp activated protein kinase
AMP-PCP: β,γ-methyleniadenosine 5'-triphosphate ATP: adenosine-5-triphosphate
ASC: association with SNF1 kinase
ATP-γ: adenosine-5'-O-(3-thiotriphosphate)
β: beta
BKCa: maxi K+ potassium channel
° C: degrees centigrade
Ca2+: calcium
[Ca2+]i: intracellular calcium
CamKKβ: cam kinase kinase beta
CB: carotid body
CO: carbon monoxide
CO2: carbon dioxide
commNTS: commissural nucleus tractus solitarius
cNTS: caudal nucleus tractus solitarius
CSN: carotid sinus nerve
CBS: cystathionine β synthase
CSE: cystathionine-γ-lyase
DA: dopamine
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DAT: dopamine transporter
DNA: deoxyribonucleic acid
dsDNA: double stranded deoxyribonucleic acid
F: frequency
FCCP: p-trifluorometoxyphenyl hydrazone
Fl: flox
γ: gamma
GBD: glycogen binding domain
g: gram
GTP: guanosine triphosphate
H+: hydrogen
HC: hypercapnia
HCO3-: bicarbonate
Hif-1: hypoxia inducible factor 1
HO-2: heme oxygenase-2
H2S: hydrogen sulfphide
HVD: hypoxic ventilatory decline
HVR: hypoxic ventilatory response
K+: potassium
kDa: kilodalton
KIS: kinase interaction sequence
KO: knockout
Kv: voltage-gated potassium channel
LKB1: liver kinase B1
L/min: liters per minute
Mg2+: magnesium
µM: micromolar
mM: millimolar
min: minute
MO25α: mouse protein 25-α
mmHg: millimeters of mercury
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ms: millisecond
mV: millivolt
N2: nitrogen
Na+: sodium
NADH: nicotinamide adenine dinucleotide
NADPH: nicotinamide adenine dinucleotide phosphate
NE: norepinephrine
NO: nitric oxide
NT: neurotransmitter
NTS: nucleus tractus solitarius
O2: oxygen
PAC: peripheral arterial chemoreceptor
PCR: polymerase chain reaction
PO2: partial pressure of oxygen
PCO2: partial pressure of carbon dioxide
pHi: intracellular pH
pHo: extracellular pH
P.S.I.: pounds per square inch
R: respiratory ratio
RISC: ribonucleic acid induced silencing complex
RR: respiration rate
RTN: retrotrapezoid nucleus
RT-PCR: reverse transcriptase polymerase chain reaction
shRNA: short hairpin ribonucleic acid
SIDS: sudden infant death syndrome
siRNA: small interfering ribonucleic acid
STPD: standard temperature and pressure under dry conditions
STRADα: ste 20-related adaptor protein-α
Sub P: substance P
TASK: acid (or alkali) sensitive K+-channels of the tandem P-domain K+-channel
family
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TH: tyrosine hydroxylase
Thr-172: threonine 172
UTP: uridine triphosphate
.
V CO2: carbon dioxide excretion
VE: minute ventilation
VE/g: minute ventilation/gram
.
V O2: oxygen consumption
VT: tidal volume
WT: wildtype
ZMP: 5-aminoimidazole-4-carboxamide ribose monophosphate
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